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The following document is in partial fulfillment of the Doctor of Philosophy 
degree. I believe this is true; no single document could contain all of the 
components which measure an individuals worthiness to receive such a degree, if 
such can be measured. I believe an individuals’ philosophy is made up of 
experiences as well as higher-learning. Certainly, just as knowledge of a particular 
field is learned, a person’s philosophy is also learned to a certain extent. The 
components of my philosophy begin with God, my creator. Secondly, my mom and 
dad, who taught me to work hard physically and mentally, have influenced my 
philosophy of life. The words from Ecclesiastes 9:10,“Whatsoever thy hand findeth 
to do, do it with thy might; for there is no work, nor device, nor knowledge, nor 
wisdom, in the grave, whither thou goest”, have special meaning to me. On a 
lighter side, other occurrences and experiences have also influenced my philosophy. 
One of the things I try to remember occasionally is the world according to Freddy 
from Jimmy Buffett’s Tales Fmm Margaritaville (pg 185). Lesson One: Never 
forget—they are always the enemy. Lesson Two: Just remember, [some people] are 
bom that way, and they usually don’t change. Lesson Three: You do not want to go 
to jail. Lesson Four: When you start to take this job seriously, you’re in trouble. 
Lesson Five: It takes more time to see the good side of life than it takes to see the 
bad. Lesson Six: If you decide to run with the ball, just count on fumbling and
v
getting the [stuffing] knocked out of you a lot, but never forget how much fun it is 
just to be able to run with the ball. Although I consider myself to be more refined 
than Freddy, the crude words do not discount their truthfulness in life. May the 
following document be just another component of the lifelong development of my 




PR E FA C E .............................................................................................  v
LIST OF TABLES........................................................................................................ ix
LIST OF FIG U R E S..................................................................................................... xi
LIST OF ABBREVIATIONS .................................................................................  xii
ABSTRACT.............................................................................................................. xv
CHAPTER
I. INTRODUCTION ...........................................................................................  1
H. REVIEW OF IJTERATURE ............................................................................ 3
Introduction............................................................................................................3
Genera] .................................................................................................................3
Growth Performance......................................................................   4
Body Composition ............................................  5
Metabolism............................................................................................................6
HI. EFFECT OF DIETARY CHROMIUM SOURCE ON GROWTH, CARCASS
CHARACTERISTICS, TISSUE CHROMIUM CONCENTRATIONS, AND 
PLASMA METABOLITE AND HORMONE CONCENTRATIONS IN
GROWING-FINISHING PIGS ..................................................................... 16
Introduction......................................................................................................  16
Materials and M ethods....................................................................................  17
Results........................................................   23
Discussion ...................................................................................................  35
Implications ...................................................................................................  42
IV. EFFECT OF DIETARY CHROMIUM SOURCE ON GLUCOSE 
TOLERANCE AND INSULIN SENSITIVITY IN GROWING PIGS . . .  43
Introduction...................................................................................................... 43
Materials and M ethods.........................................................  44
Results and Discussion.................................................................................... 49
Implications ...................................................................................................  60
V. INTERACTIVE EFFECTS OF DIETARY CHROMIUM 
TRIPICOUNATE AND CRUDE PROTEIN LEVEL IN GROWING- 
FINISHING PIGS PROVIDED INADEQUATE AND 
ADEQUATE PEN SPACE: EFFECTS ON GROWTH PERFORMANCE, 
CARCASS CHARACTERISTICS, AND PLASMA METABOLITES AND
HORMONES ................................................................................................. 61
Introduction...................................................................................................... 61
Materials and M ethods...................................................................................  62
Results............................................  67
Discussion ...........................................................   74
Implications ........................., ........................................................................ 79
VI. EFFECT OF DIETARY CHROMIUM TRIPICOUNATE ON GROWTH 
PERFORMANCE, BODY COMPOSITION, PLASMA METABOLITES 
AND HORMONES, AND GLUCOSE TOLERANCE AND INSULIN
SENSITIVITY IN BROILERS....................................................................... 80
Introduction......................................................................................................  80
Materials and M ethods.................................................................................... 81
Results........................................................................................   95
Discussion ........................................................................................................107
Implications ..................................................................................................... 117




3.1 Composition of the basal diets, as-fed b a s is ......................................  18
3.2 Effect of dietary chromium source on growth 
performance and carcass characteristics of
growing-finishing p i g s ....................   25
3.3 Effect of dietary chromium source on serum 
glucose, NEFA, insulin, and growth hormone
concentrations in growing-finishing p ig s ..........................................  27
3.4 Effect o f dietary chromium source on serum 
urea nitrogen, cholesterol, and triacylgycerol
concentrations of growing-finishing p ig s ..........................................  29
3.5 Effect of dietary chromium source on tissue 
chromium, copper, zinc, and iron
concentrations of p ig s .........................................................................  32
4.1 Composition of the basal diet, as-fed basis.........................................  45
4.2 Effect of dietary chromium source on daily gain, 
feed intake, and gain/feed in growing barrows
(Trial 1 and Trial 2 com bined).........................................................  50
4.3 Effect of dietary chromium source on plasma
metabolites and hormones in growing b arro w s................................ 51
4.4 Effect of dietary chromium source on glucose
kinetics in growing barrow s............................................................... 53
4.5 Effect of dietary chromium source on insulin
kinetics in growing barrow s............................................................... 54
5.1 Composition of the basal diets, as-fed b a s is ......................................  63
5.2 Effect of dietary chromium, crude protein level, 
and pen space on growth performance and
carcass characteristics of growing-finishing p i g s .............................  68
ix
5.3 Effect of dietary chromium, crude protein level, 
and pen space on plasma glucose, NEFA, insulin, 
and growth hormone concentrations of
growing-finishing p i g s ......................................................................  72
6.1 Composition of the basal diet, as-fed basis (Exp. 1 ) ........................  82
6.2 Composition of the basal diet, as-fed basis (Exp. 2 ) ........................  85
6.3 Composition of the basal diets, as-fed basis (Exp. 3 ) ...................... 87
6.4 Composition of the basal diets, as-fed basis (Exp. 4 ) ...................... 90
6.5 Effect of dietary chromium on growth performance,
N balance, and breast and leg muscle and whole-body
composition of 5 to 19-day-old broilers (Exp. 1 ) .............................  96.
6.6 Effect of dietary chromium on growth performance, 
organ weights, body composition, and plasma
metabolites and hormones of 5 to 33-day-old broilers (Exp. 2) . . . 97
6.7 Effect of dietary chromium on growth performance
of 5 to 54-day-old broilers (Exp. 3 ) ....................................................100
6.8 Effect of dietary chromium on organ and tissue
weights of 5 to 54-day-old broilers (Exp. 3 ) .......................................102
6.9 Effect of dietary chromium on plasma metabolites
and hormones of 5 to 54-day-old broilers (Exp. 3) ..........................103
6.10 Effect of dietary chromium on body composition
of 5 to 54-day-old broilers (Exp. 3 ) ....................................................105
6.11 Effect of dietary chromium on growth performance,
and glucose and insulin clearance in broilers (Exp. 4) .....................108
x
LIST OF FIGURES
4.1 Effect o f dietary chromium on glucose tolerance
in pigs during an intravenous glucose tolerance t e s t ........................  55
4.2 Effect of dietary chromium on insulin clearance in
pigs during an intravenous glucose tolerance te s t .............................  56
4.3 Effect of dietary chromium on glucose clearance
in pigs during an intravenous insulin challenge t e s t ........................  57
4.4 Effect o f dietary chromium on insulin clearance
in pigs during an intravenous insulin challenge t e s t ........................ 58
6.1 Effect of dietary chromium on glucose clearance
in broilers during an intravenous glucose tolerance te s t .....................109
6.2 Effect of dietary chromium on insulin clearance
in broilers during an intravenous glucose tolerance te s t .....................110
6.3 Effect of dietary chromium on glucose clearance
in broilers during an intravenous insulin challenge t e s t .....................I l l
6.4 Effect of dietary chromium on plasma glucose 
concentration in broilers during a least-sampling
minimal model (LSMM) glucose tolerance test  .......................... 112
6.5 Effect o f dietary chromium on plasma glucagon 
concentration in broilers during a least-sampling
minimal model (LSMM) glucose tolerance te s t ..................................113
xi
LIST OF ABBREVIATIONS
ADFI  average daily feed intake
A D G .....................................................................................  average daily gain
B W  body weight
Ca .........................................................................................................................calcium
C P   crude protein
Cr ................................................................................................................. chromium
C rA c chromium acetate
C r C l  chromium chloride hexahydrate
C rN G C G ........................  chromium-nicotinate-glutamate-cysteine-glycine complex
C r N ic .............................................................................................. chromium nicotinate
C rO x  chromium oxalate
CrPic ........................................................................................  chromium tripicolinate
Cu .......................................................................................................................... copper
C V ............................................................................................ coefficient of variation
D a rk ................................................................................................... leg plus thigh meat
DM ..............................................................................................................  dry matter
D P ...................................................................................................  dressing percentage
E D T A ............................................................................ ethylenediaminetetraacetic acid
Fe ............................................................................................................................ iron
F S H .................................................................................... follicle stimulating hormone
xii
G H .....................................................................................................  growth hormone
G L M  general linear model
G T F ........................................................................................ glucose tolerance factor
G u t......................................................................................digestive tract plus organs
h ..............................................................................  hour
H D L ........................................................................................ high density lipoprotein
I ................................................................................................................................iodine
IVGTT ....................................................................intravenous glucose tolerance test
IV IC T ...................................................................... intravenous insulin challenge test
1 c ............................................................................................................. clearance rate
L B M .........................................................................................................lean body mass
L D L ......................................................................................... low density lipoprotein
L H ...........................................................................  luteinizing hormone
L M A .............................................................................   longissimus muscle area
L S D ................................................................................... least significant difference




N E F A ......................................................................................  nonesterified fatty acid
PBS  ................................................................................... phosphate buffered saline
p G H ...................................................................................... porcine growth hormone
P M ............................................................ ..............................percentage of muscling
p p b ........................................................................................................ parts per billion
ppm ...................................................................................................  parts per million
ppS T ................................................................................ porcine pituitary somatotropin
RIA ....................................................................................................radioimmunoassay
R N A ........................................................................................... ..  ribonucleic acid
S e ...................................................................................................................... selenium
T R F ..........................................................................................................  tenth rib fat
T P N ......................................................................................  total parenteral nutrition
T t n ........................................................................................................................half-life
w k .............................................................................................................................week
W h ite ........................................................................................................... breast meat
Zn ...........................................................................................................................  zinc
ABSTRACT
Three experiments were conducted with pigs and four experiments were 
conducted with chickens to determine the effects of supplemental dietary Cr on 
growth performance, carcass characteristics, tissue minerals and plasma metabolite 
and hormone concentrations. In pigs (Exp. 1) 200 ppb Cr from seven different 
sources tended to decrease growth performance during the grower phase and 
increase growth performance during the finisher phase. Dietary Cr had minimal 
effects on plasma metabolite and hormone concentrations and Cr did not affect 
carcass characteristics. In general, dietary Cr increased tissue Cr concentration, 
except for longissimus muscle (LM). In Exp. 2, pigs were fed 400 ppb Cr as Cr 
chloride, Cr nicotmate, or Cr picolinate (CrPic) to determine the effect of these Cr 
sources on i.v. glucose tolerance and insulin sensitivity. None of the Cr sources 
affected glucose clearance rate or half-life, or insulin clearance rate or half-life. In 
Exp. 3, the interactive effects of two levels o f dietary lysine, two levels of dietary 
Cr, and two levels of pen space were evaluated. During the finisher phase, Cr 
increased average daily gain and gain/feed o f pigs fed 80% of the lysine requirement 
but not in pigs fed 120% of the lysine requirement. In addition, Cr decreased tenth 
rib fat thickness (TRF) in pigs given adequate pen space but increased TRF of pigs 
given inadequate pen space. Dietary Cr supplementation did not affect LM area. 
Three experiments were conducted to determine the effect of CrPic on growth 
performance, plasma metabolites and hormones, and carcass composition of
xv
broilers. In broilers fed CrPic for two weeks, Cr decreased percentage of dry 
matter of the carcass and tended to decrease percentage carcass fat. In broilers fed 
CrPic for four weeks, Cr supplementation increased ventriculus weight and 
increased carcass ash percentage. In broilers fed CrPic for seven weeks, Cr 
decreased abdominal fat pad weight. Dietary Cr had minimal effects on plasma 
metabolites and hormones in broilers. In a fourth experiment with broilers, CrPic 
did not affect glucose tolerance or insulin sensitivity. Under the conditions of these 




Dietary chromium (Cr) has been reported to have beneficial effects in many 
aspects of the metabolism of man and animals. Chromium is believed to function by 
facilitating the action of insulin. Some of the historic findings in Cr nutrition 
include improvements in glucose tolerance and insulin sensitivity, as well as plasma 
lipid status, in man and animals. Recently some researchers have reported dramatic 
improvements in body composition of growing-finishing pigs that were fed Cr 
tripicolinate (CrPic), an organic source of Cr, but not pigs that were fed Cr chloride 
(CrCl), an inorganic source of Cr. Specifically, these researchers have reported 
increased longissimus muscle area and decreased tenth rib fat thickness in pigs fed 
CrPic. Other researchers have reported increased clearance rate of glucose in pigs 
fed CrPic.
Additional research, primarily in ruminants, suggests that Cr improves the 
immune status of livestock. This research indicated that it was necessary for an 
animal to be stressed to elicit a  response to Cr supplementation. If Cr is to become 
a feed additive for the feed industry in the United States (Cr is approved for use in 
some foreign countries), then the specific conditions (environment, etc.) in which Cr 
is beneficial to the animal need to be characterized. In addition, forms of Cr 
(organic and inorganic) other than CrPic and CrCl need to be evaluated. Therefore, 
the following experiments were conducted to evaluate the effects of form of Cr and
environmental stress (decreased pen size) on growth performance, carcass 
characteristics, and metabolic status of growing-finishing pigs. In addition, 
experiments also were conducted to evaluate the effect of CrPic in broiler diets 
growth performance, body composition, and glucose tolerance and insulin 
sensitivity.
CHAPTER n  
REVIEW OF LITERATURE
Introduction
There have been many excellent reviews (Anderson, 1981, 1986, 1989; 
Ducros, 1992; Hambidge, 1974; Mertz 1969, 1993; M ertzetal., 1974; Offenbacher 
and Pi-Sunyer, 1988; Saner, 1986; Wallach, 1985) and book chapters (Anderson, 
1987; Anderson, 1988a,b; Canfield, 1979; Doisy e ta l., 1976; Linder, 1985; Mertz, 
1975, 1979, 1982; Saner, 1979) written about Cr nutrition. Certainly the most 
comprehensive review of the Cr literature was by Mertz (1969). Many of the 
aspects that were covered in that review will not be covered in the current review. 
Some of these topics include the chemistry of Cr, Cr in plants, and Cr analysis 
methodology. These topics are important but not the primary focus of the current 
body of research. Many of the reviews that have been written segregate human 
from animal literature. The present review will include the current pertinent 
literature regarding Cr in man and animals. Specifically, this review will 
concentrate on the effects of Cr on growth performance, body composition, 
metabolism, and immune function.
General
The essentiality of Cr in humans has been well documented. The most 
convincing evidence was the dramatic recovery of TPN patients that displayed signs
of diabetes (Jeejeebhoy et al., 1977). In fact, the suggested safe and adequate daily 
intake for Cr is SO to 200 pig, as established by a  panel of the United States National 
Academy of Sciences (NAS, 1980). However, the typical diet does not meet the 
suggested daily intake (Anderson and Kozlovsky, 1985). Foods that contain higher 
concentrations of Cr typically are not eaten in large quantities (e.g., mushrooms, 
brewer's yeast, black pepper, prunes, raisins, nuts; Anderson, 1988). Refined foods 
have lower amounts of Cr than unrefined foods (Anderson, 1988). Recent evidence 
suggests that animal foodstuffs also may not contain adequate Cr to meet the 
animals’ requirement (Page et al., 1993).
Growth Performance 
The literature regarding the effects of dietary Cr on growth performance of 
animals is equivocal. Early work by Schroeder et al. (1963a,b) showed that dietary 
Cr improved the growth rate of mice and rats. However, more recent data with 
livestock species has yielded variable results. In a publication which contained 
multiple experiments, Page et al. (1993) reported increased, decreased, and no 
change in growth rate of pigs due to dietary Cr supplementation as chromium 
tripicolinate (CrPic). Lindemann et al. (1993) reported that pigs fed marginal lysine 
(or crude protein) diets had improved growth performance and feed efficiency in 
response to CrPic supplementation; however, pigs fed diets adequate in lysine did 
not have improved growth performance when fed CrPic. Other investigators have 
reported no effect of dietary Cr supplementation on growth performance of pigs
(Page et al., 1993a; Renteria and Cuardn, 1993), lambs (Kitchalong et al., 1995), 
calves (Bunting et al., 1994), or steers (Claeys et al., 1994).
Body Composition
The work that initiated the most recent thrust of Cr research was the finding 
by Page et al. (1993b) that dietary Cr supplementation as CrPic (an organic source 
o f Cr) dramatically improved body composition of pigs. Specifically, 
supplementation of typical com-soybean meal diets with 200 to 400 ppb Cr as CrPic 
increased longissimus muscle area and decreased tenth rib fat thickness. These two 
carcass traits are of significant economic value to an industry that is trying to 
maintain (or gain) market share in an increasingly competitive environment. 
Furthermore, the necessity of the organic form of Cr for improved body 
composition of pigs was discovered (Page et al., 1993a,b).
After the initial data of Page et al. (1993b), other investigators have reported 
similar improvements in body composition due to dietary Cr supplementation from 
organic sources. Lindemann et al. (1995) reported decreased tenth rib backfat 
thickness and increased longissimus muscle area in pigs fed CrPic. Other authors 
have reported more subtle differences in body composition. Boleman et al. (1995) 
and Mooney and Cromwell (1995) both reported little to no effect of dietary Cr as 
CrPic on the linear carcass measurements of pigs. However, carcass dissection and 
whole-body composition analysis revealed that dietary Cr increased the rate o f lean
deposition and decreased the rate of fat deposition in pigs. Smith et al. (1994) also 
reported decreased backfat thickness of pigs fed Cr nicotinate (CrNic).
Kitchalong et al. (1995) reported that dietary Cr as CrPic supplementation 
decreased fat thickness over the tenth rib of lambs. Conversely, Claeys et al. (1994) 
reported higher quality grades for steers fed CrNic (thus increased intermuscular fat) 
and decreased ribeye area of steers fed 400 ppb Cr as CrCl or 800 ppb Cr as CrNic. 
Hasten et al. (1992) reported that female students that were beginning weight 
training had increased body weight (BW), primarily due to increased lean body mass 
(LBM). However, male students showed no change in BW or body composition 
due to Cr supplementation. Evans (1989) reported that male football players had 
increased BW, LBM, and calf circumference when they combined dietary Cr 
supplementation with weight training. However, Alniada et al. (1995) reported no 
beneficial effect of a nutritional supplement that contained Cr as CrPic on males 
during resistance training. Other authors have reported increased LBM (Hasten et 
al., 1993) and decreased body fat (Hasten et al., 1994, 1995) in rats.
Metabolism
Introduction. The reason for the increased lean and decreased fat in the bodies 
o f humans and carcasses of animals given supplemental dietary Cr is not known. 
However, Cr is known to be involved in a myriad of steps of metabolism, including 
protein, carbohydrate, and lipid metabolism. Chromium is thought to exert its 
effects through the potentiation of insulin action. However, the anabolic nature, and
more specifically, the lipogenic nature of insulin makes the proposed mechanism of 
action of Cr more puzzling. The mystery probably is confounded by the fact, that 
after decades of research, the cellular mechanism of action of insulin is not well 
established.
Erotein. Apart from the multitude of reports from around the world of 
increased muscling o f animals and humans given supplemental dietary Cr, little 
research has been conducted to determine the cellular or molecular mechanisms 
behind this occurrence. Britton et al. (1968) reported that lambs fed molasses or Cr 
as CrCl had increased N utilization. This would suggest that changes in lean 
composition that have since been reported by other authors also may have occurred; 
body composition was not determined in that experiment. Other investigators have 
attempted to study the cellular mechanism of action of Cr. Ono et al. (1994) 
reported that supplemental dietary Cr for pigs injected with porcine somatotropin 
resulted in increased muscle fiber area compared to pigs injected with somatotropin 
only. Dietary Cr alone did not affect muscle fiber area. Morris et al. (1994) 
reported no effect of dietary Cr supplementation on cardiac growth, protein, or 
myofibrillar protein content. Hasten et al. (1995) reported that rat skeletal 
myoblasts had increased 3H-leucine uptake, suggesting perhaps an enhancement of 
protein synthesis. Rats treated with an intraperitoneal dose of Cr as CrCl had 
increased nucleolar and ribosomal RNA synthesis (Okada et al., 1984). However, 
the true implications of Cr for protein synthesis are not known.
Lipid. Low serum Cr has been correlated with coronary artery disease in 
humans (Newman et al., 1978; Schroeder et al., 1970; Simonoff et al., 1984).
Riales (1979) reported that brewer's yeast (containing Cr) increased HDL- 
cholesterol and decreased LDL-cholesterol without affecting total serum cholesterol. 
These findings are consistent with others that have postulated that Cr is responsible 
for such effects (Riales and Albrink, 1981; Elwood et al., 1982; Roeback et al., 
1991; Abraham et al., 1992). In fact, Abraham et al. (1980; 1991) reported that Cr 
supplementation of rabbits reduced the surface area of aortic plaques that had been 
induced by feeding cholesterol.
Press et al. (1990) reported that supplemental CrPic decreased total 
cholesterol, LDL-cholesterol, and apolipoprotein B (the principal protein of the LDL 
fraction). Supplemental Cr as CrPic also increased apolipoprotein A-l, the principal 
protein of the HDL fraction, but did not significantly affect HDL-choIesterol 
concentration. However, Hermann et al. (1995) reported that Cr as CrCl was 
effective in lowering serum total cholesterol but increased apolipoprotein B in adults 
over age fifty. Lefavi et al. (1991) reported that a nicotinic acid-chromium complex 
was effective in reducing serum total cholesterol and increasing the total 
cholesterol:HDL-cholesterol ratio in male athletes. In addition, Schroeder (1968) 
and Schroeder et al. (1971) reported that supplemental Cr reduced serum total 
cholesterol in rats and Kitchalong et al. (1995) reported that supplemental Cr 
reduced serum cholesterol and NEFA in lambs. In addition, CrPic supplementation
has been reported to decrease serum total cholesterol concentrations in pigs (Page et 
al., 1993b), lambs (Kitchalong et al., 1995), and calves (Bunting et al., 1994). 
However, Rabinowitz et al. (1983) reported that CrCl, brewer's yeast containing 
glucose tolerance factor (GTF), and brewer’s yeast without GTF did not affect 
plasma total cholesterol or triglycerides in diabetic men and Amoikon et al. (1995) 
reported that CrPic increased serum total cholesterol in pigs. However, it is 
possible that changes in the lipoprotein fractions did occur in that study but were not 
detected (i.e., they were not measured). Other investigators also have reported a 
lack of effect of dietary Cr on lipid measurements in humans (Gondy and Wilson, 
1994; Thomas and Gropper, 1995), chickens (Maurice and Jensen, 1978), calves 
(Bunting et a)., 1994), and lambs (Kitchalong et al., 1995).
Glucose and Insulin. It is difficult to separate the effect of Cr on glucose and 
insulin metabolism. However, the glucose and insulin responses to dietary Cr will 
be separated. One of the first defined roles of Cr in mammals was the alleviation of 
hyperglycemia in rats (Mertz et al., 1961, 1965, 1969; Schroeder, 1966). The most 
striking evidence for the efficacy of Cr in alleviating hyperglycemia is in total 
parenteral nutrition (TPN) patients (Jeejeebhoy et al., 1977; Freund et al., 1979). 
These patients required insulin injections to lower their blood glucose levels. 
However, following the addition of Cr to the TPN solution, the requirement for 
insulin was dramatically decreased, if not completely negated. The symptoms of 
diabetes also were alleviated. Further evidence of a role for Cr in glucose
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homeostasis was found for Turner’s syndrome patients. Supplemental Cr was 
effective in decreasing hyperglycemia in these patients (Saner et al., 1983).
Other investigators have reported equivocal responses from supplementing the 
diets of the elderly with Cr. Offenbacher and Pi-Sunyer (1980) reported that 
chromium-rich brewer’s yeast improved glucose tolerance of elderly subjects. 
Similarly, Potter et al. (1985) reported that Cr as CrCl was effective in lowering the 
plasma glucose response to an oral glucose tolerance test, but plasma insulin levels 
were not affected. Bourn et al. (1985) reported that Cr supplementation was 
effective in lowering plasma glucose and insulin concentrations in post-menopausal 
women. However, Martinez et al. (1985) and Offenbacher et al. (1985) reported 
that supplemental Cr did not change glucose tolerance or insulin status in elderly 
subjects. Mossop (1983) and Vinson and Bose (1984) reported that diabetic patients 
had lower fasting plasma glucose concentrations when they received supplemental 
dietary Cr. However, other investigators have found no response to supplemental 
Cr in diabetic patients (Sherman et al., 1968; Uusitupa et al.t 1983, 1992). The 
reasons for these different results are not clear. Some investigators have suggested 
that only those patients with abnormal glucose tolerance will respond to Cr 
supplementation. However, previously in the text it was noted that diabetic patients 
did not always respond to Cr supplementation. The unknown factors of diabetes and 
its associated complications makes it a challenging subject. Glinsmann and Mertz
(1966) reported that diabetic patients responded to Cr supplementation, but patients
with normal glucose tolerance did not. Freiberg et al. (1975) reported that diabetic 
or “doubtful1 (marginal diabetics) patients had lowered plasma glucose after 
supplementation with brewer’s yeast, presumably due to its Cr content. Anderson et 
al. (1991), Uu et al. (1977, 1978), and Polansky et al. (1991) reported similar 
findings comparing patients with normal and abnormal glucose tolerance. Anderson 
et al. (1985, 1987) reported that both hypoglycemic and hyperglycemic subjects had 
improved glucose status when they received supplemental Cr. However, Evans 
(1989) and Levine et al. (1968) reported that some patients with abnormal glucose 
tolerance responded to Cr supplementation, but other patients with abnormal glucose 
tolerance did not respond to Cr supplementation. The unknown cause(s) of 
"responders” and "nonresponders" further complicate the study of Cr nutrition in man 
and animals.
The animal data with glucose response to Cr supplementation are just as 
variable as the human data. Some investigators have found that supplemental Cr 
decreased plasma glucose concentrations, whereas others have reported no effect of 
supplemental Cr on glucose status of animals. Stoecker and Oladut (1985) reported 
that Cr supplementation lowered the plasma glucose response 60 min after a  glucose 
tolerance test in guinea pigs. This may indicate that glucose was cleared from the 
plasma at a foster rate; however, clearance rate was not determined. Similarly, 
Amoikon et al. (1995) reported that supplemental Cr as CrPic increased the 
clearance rate and decreased the half-life of glucose from the plasma of pigs during
an intravenous glucose tolerance test (IVGTT). In a like fashion, Cr as CrPic has 
been reported to increase glucose clearance rate in calves (Bunting et al., 1994) and 
lower glucose response to IVGTT in lambs (Kitchalong et a l., 1995). Evock-Clover 
et al. (1993) also reported that supplemental dietary Cr as CrPic was effective in 
“normalizing” the plasma glucose levels of pigs injected with porcine somatotropin. 
However, other investigators have found no effect of supplemental Cr on the glucose 
tolerance of steers (Claeys et al., 1994), lambs (Fomea et al., 1994; Sam sell and 
Spears, 1989), or hens (Jensen et a l., 1978).
Some investigators have suggested that Cr directly affects the endocrine 
pancreas. However, there is a lack of agreement about the direction of these effects. 
Ghafghazi et al. (1980) reported that Cr decreased insulin secretion in isolated 
pancreatic islets. However, Strifrier et al. (1993) reported that dietary Cr enhanced 
insulin secretion in perfused rat pancreas. Hubner et al. (1989) reported that dietary 
Cr decreased insulin response to an i.p. glucose tolerance test in gestating rats. 
Furthermore, the insulin content o f the entire pancreas o f these dams was decreased, 
but the insulin content of the entire pancreas from the neonatal rats (from the Cr 
supplemented dams) was increased. It is interesting that these rats supplemented 
with Cr did not have a change in their glucose tolerance, yet insulin secretion was 
obviously affected by Cr.
Some investigators have reported that supplemental dietary Cr differentially 
affects insulin binding in tissues. Ward et al. (1994) reported that dietary Cr as
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CrPic decreased insulin binding to plasma membranes of pig liver cells. Berrio et 
al. (1995), from the same laboratory, reported that dietary Cr as CrPic increased 
insulin binding in isolated pig fat cells and erythrocyte membranes. These data may 
indicate that Cr decreases glucose utilization by the liver, and therefore more 
glucose is available for uptake by peripheral tissues. However, Steele et al. (1982) 
reported that dietary Cr as CrCl did not affect insulin binding in hepatic tissues.
The discrepancy between these findings and those of Ward et al. (1994) might be 
explained by the difference in forms of dietary Cr. Ward et al. (1994) used an 
organic source of Cr (CrPic).
Other investigators have indicated that Cr may act on the enzymes of 
gluconeogenesis and glycolysis. Shiau and Chen (1993) reported that supplemental 
dietary Cr lowered glucose-6-phosphatase activity in tilapia, but phosphofructokinase 
activity was higher in tilapia supplemented with Cr. These same investigators found 
that C r supplementation increased weight gain, energy deposition, and liver 
glycogen content in fish fed glucose as a carbohydrate source. Campbell et al.
(1989) reported that dietary Cr enhanced liver glycogen synthase activity in 
sedentary rats but not in exercise-trained rats.
Stress and Immune Function. Some investigators have postulated that some 
type o f "stress” must be imposed before a subject will respond to Cr 
supplementation (Anderson, 1994; Waddington, 1994). Indeed, Mertz and Roginski
(1967) found that rats fed a low-Cr, low-protein diet had depressed growth and this
growth depression was alleviated by supplementing the diet with Cr. Subjecting the 
rats to exercise or excessive bleeding also improved growth and survivability in 
response to supplemental Cr. Exercise, physical trauma, and high sugar intake have 
been reported to increase Cr losses in man (Anderson, 1982, 1988, 1989). Other 
investigators also have shown a negative correlation between plasma Cr and plasma 
glucose levels (Morris et al., 1988a,b).
The relationship between Cr status and glucose utilization may be further 
strained by physiological stress. Pekarek et al. (1975) reported that acute infection 
with sandfly fever dramatically decreased serum Cr levels and glucose disappearance 
rates in humans. Investigators in the animal sciences also have indicated that 
supplemental Cr may be beneficial in the presence of stressors. Chang and Mowat 
(1992) reported that transport-stressed feeder calves had reduced serum cortisol 
when they were provided supplemental dietary Cr. In addition, supplemental dietary 
Cr increased serum immunoglobulin M and total immunoglobulins in calves fed 
diets with soybean meal but had no effect in calves fed urea-com supplementation. 
Mowat et al. (1993) and Wright et al. (1993) reported that dietary Cr decreased 
morbidity in transport-stressed feeder calves. The improvements in gain and 
morbidity have been linked to immune status o f these animals. Moonsie-Shageer 
and Mowat (1993) reported that supplemental dietary Cr decreased morbidity and 
increased antibody titers and immunoglobulin Gj in stressed feeder calves. 
Supplemental Cr also increased indicators of cell-mediated immunity in
periparturient dairy cows and in dairy cows during early lactation (Burton et a l.,
1993). Other investigators have noted positive effects of Cr supplementation on 
immune status of calves (Chang et al., 1994; Lindell et al., 1994; Wright ct al. ,
1994) and pigs (van Heugten and Spears, 1994).
CHAPTER n i
EFFECT OF DIETARY CHROMIUM SOURCE ON GROWTH, CARCASS 
CHARACTERISTICS, TISSUE CHROMIUM CONCENTRATIONS, AND 
PLASMA METABOLITE AND HORMONE CONCENTRATIONS IN 
GROWING-FINISHING PIGS
Introduction
Page et al. (1993a) reported no effect of Cr chloride hcxahydrate (CrCl) on 
body composition or metabolites in pigs; however, Cr tripicolinate (CrPic) was 
reported to decrease tenth rib backfat thickness and increase longissimus muscle area 
(Page et a l., 1993a,b). Other authors have also reported improvements in body 
composition of swine from supplemental dietary CrPic (Renteria and CuanSn, 1993; 
Mooney and Cromwell, 1994; Boleman et a l., 1995; Lindemann et a l., 1995; 
Mooney and Cromwell, 1995). At least one possible reason for Ihe difference in 
response to supplemental dietary Cr may be the form of Cr. The chemical 
composition of Cr compounds has been reported to affect the biological activity of 
these compounds (Evans and Pouchnik, 1993). Page et al. (1993b) reported no 
effect of CrCl, picolinic add, or the combination of CrCl and picolinic add on body 
composition of pigs. However, the chemical complex o f Cr and picolinic acid in 
CrPic increased the proportion of muscle and decreased the proportion of fat in pigs 
(Page et a l., 1993a,b). Thus it appeals that the complex of Cr and picolinic acid (or 
perhaps some other organic molecule) is necessary for Cr to elicit beneficial effects 
on carcass composition o f pigs. Therefore, the objective of this experiment was to
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determine the effects o f different Cr sources (inorganic and organic complexes) on 
growth, carcass characteristics, metabolite and hormone concentrations, and tissue 
mineral concentrations in growing-finishing pigs.
Materials and Methods
Animals and Dietary Treatments
Crossbred (Yorkshire x Hampshire x Duroc) pigs were used [avg. initial body 
weight (BVV)=18.1 kg]. The pigs were allotted to treatment on the basis of BW in 
a randomized complete block design; ancestry was equalized across treatments.
Each treatment was replicated four times with four pigs per replicate pen. There 
were four pens o f four pigs each which were fed a control diet (no Cr 
supplementation). Sex (two gilts and two barrows) was equalized within pen.
The pigs were fed a com-soybean meal basal diet (Table 3.1) formulated to 
provide 120% of the (NRC, 1988) lysine requirement during both the grower and 
finisher phases o f production. The dietary treatments consisted of an 
unsupplemented control diet (Basal) and the Basal diet supplemented with 200 n z  
Cr/kg diet as either chromium chloride hexahydrate (CrCl; Sigma Chemical Co., 
St.Louis, MO), Cr acetate (CrAc), Cr oxalate (CrOx), Cr nicotinate (CrNic), Cr 
tripicolinate (CrPic-1; USDA source), Cr nicotinate-glycine-cysteine-glutainate 
complex (CrNGCG), or Cr tripicolinate (CrPic-2; commercial source, Nutrition
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Soybean meal, 44% CP 24.72 17.90
Defluorinated rock phosphate .75 .33
Oyster shell flour .70 .84
Salt .25 .25
Vitamin premix* .25 .25
Trace mineral premix” .05 .05
‘Provided the following per kilogram of diet: riboflavin, 4.4 mg; d- 
pantothenic acid, 22 mg; niacin, 22 mg; vitamin B12, 22 /ig; d-biolin, 220 /ig; 
choline chloride, 440 mg; vitamin A, 4400IU; vitamin D3, 4 4 0 1U; vitamin £ ,1 1  
1U; menadione dimethylpyrimidinol bisulfite, .25 mg; S e ,. 1 mg.
’’Provided the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 ntg; Mil, 
30 mg; Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.
21, San Diego, CA). Chromium acetate, CrOx, CrNic, CrPic-1, and CrNGCG were 
supplied by Dr. Richard Anderson, Nutrient Requirements and Function Laboratory, 
USDA, Beltsville, MD. These particular compounds were chosen based on the 
ability to obtain them, the use of some of them in previous research (CrPic, CrNic, 
and CrCl), and the need to evaluate additional organic compounds. The pigs were 
allowed to consume the treatment diets on an ad libitum basis. During the grower 
phase of production the pigs were penned in 1.8-m x 2.4-m pens in an enclosed 
facility with totally slatted floors. During the finisher phase of production the pigs 
were penned in l.S-m x 2.9-m pens in a curtain-sided facility with totally slatted 
floors. Pigs were switched to finisher diets when the average BW of a  block was 
approximately S3 kg. This experiment was conducted from January through April 
of 1988.
Blood Sampling
All pigs were bled via the anterior vena cava following 20 h without access to 
feed and then again at 2 h postfeeding on days 21 and 77 of the experiment. Blood 
for serum glucose and nonesterified fatty acid (NEFA) analysis was placed into 
tubes containing IS mg sodium fluoride, whereas blood for other serum metabolite 
and hormone analyses was placed into tubes without the glycolytic inhibitor. The 
blood samples were centrifuged for 20 min at 1,600 X g at 4°C. Serum was 
collected and frozen (-20 °C) for later analyses.
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Carcass Traits
Pigs were removed from the experiment when their BW was approximately 
100 kg (actual final average BW =  98.1 kg). Pigs were killed via stunning 
(electrical or captive bolt) followed by exsanguination at the Louisiana State 
University Agricultural Center Animal Science Department Meats Laboratory or a 
commercial facility. Hot carcass weights were taken with heads on the carcass and 
leaf fat in the carcass. Longissimus muscle area (LMA) at the tenth .rib interface 
and tenth rib fat (TRF) thickness three-fourths the distance from the midline were 
measured after approximately 20 h at 2°C. Longissimus muscle area and TRF were 
adjusted to 104.3 kg (National Swine Improvement Federation, 1987), and 
percentage of muscling (PM) was calculated by methods described by the National 
Pork Producers Council (1991).
Tissue samples were collected from common sections of the liver, kidney, 
pancreas, and heart o f two pigs from two replicate pens (four replicate pens for CrCl 
and CrPic-2 treatments) at the time of slaughter for tissue Cr, Zn, Cu, and Fe 
analyses. In addition, the tenth rib portion of the longissimus muscle was removed 
from the same pigs for Cr, Zn, Cu, and Fe analyses.
Chemical^Analyses
Serum was analyzed for glucose (Sigma Chemical Co, 1990) and NEFA 
(NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA, Inc., Richmond, VA) 
concentrations using spectrophotometric procedures outlined in commercially-
2 1
available kits. Serum was analyzed for total cholesterol, urea N, and triacylglycerol 
concentrations by automated “centrifichem" procedures (conducted by USDA 
personnel, Nutrient Requirements and Function Laboratory, Beltsville, MD). Tissue 
mineral analysis was conducted according to the procedure of Hill et al. (1986) 
(conducted by USDA personnel, Nutrient Requirements and Function Laboratory, 
Beltsville, MD).
Serum insulin was assayed by the RIA method of Amoikon et al. (1995). 
Guinea pig anti-bovine insulin antiserum (Code No. 65-101, Lot No. GP616; ICN 
ImmunoBiologicals, Lisle, IL) was used at a 1:60,000 final dilution. Purified 
porcine insulin (26.1 /tU/ng; Sigma Chemical Co.) and bovine ,2SI-insulin (ICN 
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand, 
respectively. Sheep anti-guinea pig antiserum produced in our laboratory was used 
at a 1:4 dilution as the precipitating antibody. The intraassay CV for the insulin 
RIA as determined by a pooled bovine plasma sample was 7.7%.
Serum GH was measured by a double-antibody RIA technique based on 
antiserum (AFP-10318545; A.F. Parlow, Pituitary Hormone and Antisera Center, 
Harbor-UCLA Medical Center, Torrance, CA) against porcine GH (pGH). Highly 
purified pGH was radioiodinated via the chloramine-T method (Greenwood et al., 
1963; 2.5 ng  o f chloramine-T//ig of GH, 0 °C for 30 sec). The antiserum was 
diluted 1:150,000 in PBS containing .033 M EDTA, .112% normal rhesus monkey 
serum (Calbiochem, San Diego, CA), and 33% noninhibitory horse serum; 300 piL
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of this solution was used per tube. The horse serum was added to minimize and to 
stabilize nonspecific binding of radioiodinated pGH to the assay tubes. Anti serum 
(Calbiochem) against rhesus monkey immunoglobulin-G was diluted 1:21 and was 
used at 200 pL per tube to precipitate the primary antibody. Cross-reactivities of 
other porcine pituitary hormones in the assay were as follows (percentage relative to 
pGH): prolactin, .08; FSH, .12; LH, .001; and thyroid-stimulating hormone, .004 
(A.F. Parlow, personal communication). Inhibition curves produced by serial 
dilutions of porcine sera and pituitary extracts were parallel to those produced by the 
reference standard (USDA-pGH-Bl; National Hormone and Pituitary Agency, 
Baltimore, MD). Sensitivity of the assay averaged . 1 ng; the sample size was 200 
(iL  in a typical assay. Intra- and interassay CV in the GH RIA were 9.6 and 9.8%, 
respectively.
Statistical Analyses
Data from these experiments were analyzed by ANOVA (Steel and Torrie, 
1980) using the general linear model (GLM) procedure of SAS (198S). The data 
were analyzed as a randomized complete block design with initial BW as the 
blocking factor. The pen of pigs was the experimental unit for all data. Statistical 
analysis of dressing percentage included final BW in the model as a covariate. Data 
are presented as means with LSD means separation procedures to indicate treatment 
differences at P <  .05, unless otherwise indicated. In addition, a single degree-of-
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freedom contrast was done to compare the main effect of Cr supplementation (i.e., 
the basal diet vs all Cr diets).
Results
Growth Performance
During the grower phase of production, average daily gain (ADG) was 
reduced (P <  .01) in pigs fed Cr (basal diet vs all Cr diets, Table 3.2). Average 
daily gain was reduced (P <  .05) in pigs fed CrCl, CrAc, or CrOx compared with 
the pigs fed the basal diet (Table 3.2). Chromium supplementation as CrNic, CrPic- 
1, CrNGCG, or CrPic-2 resulted in intermediate ADG. The decreased ADG did not 
result (P >  .05) from differences in feed intake, although there was a tendency 
(P <  . 12) for Cr to decrease feed intake; therefore, differences in feed efficiency 
were observed. Pigs fed CrCl were less efficient (P < .05) than pigs ted CrAc, 
CrOx, CrNic, CrPic-1, or CrPic-2. However, pigs fed the basal diet or CrNGCG 
had intermediate gain:feed.
During the finisher phase of production the main effect of Cr was opposite of 
that observed during the grower phase. Pigs fed diets containing Cr tended to eat 
more feed (P <  . 17) and gain more weight (P <  . 10). Average daily gain was 
lower (P <  .05) for pigs fed CrOx than for pigs fed CrPic-2; pigs fed the other 
dietary treatments had intermediate (P >  .05) ADG. The response to supplemental 
Cr was more variable during the finisher phase compared with the grower phase.
Pigs fed CrCl had greater (P <  .05) average daily feed intake (ADFI) than pigs fed
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the basal diet or CrAc, CrOx, or CrPic-1. Pigs fed CrPic-1, CrPic-2, and CrNGCG 
had greater (P <  .05) ADFI than pigs fed CrAc or CrOx.
During the overall combined grower and finisher phases there was no main 
effect of Cr (P >  .20). Average daily gain of pigs fed CrOx was lower than ADG 
of pigs fed CrNic, CrNGCG, or CrPic-2. Pigs fed the basal diet or CrCl, CrAc, or 
CrPic-1 had intermediate ADG. Pigs fed CrCl or CrNGCG had greater ( P <  .05) 
ADFI than pigs fed CrAc, CrOx, or CrPic-1. Pigs fed the basal diet, CrNic, or 
CrPic-2 had intermediate ADFI. Feed efficiency was less (P <  .05) in pigs fed 
CrCl compared with pigs fed CrAc, CjOx, CrNic, CrPic-1, or CrPic-2. Pigs fed 
the basal diet or CrNGCG had intermediate feed efficiency.
fa m iM  Traits
Longissimus muscle area, TRF, and PM were not affected (P >  .05) by 
dietary treatment (Table 3.2). Dressing percentage was less (P <  .05) in pigs fed 
CrAc or CrOx compared with pigs fed CrCl. Pigs fed the basal diet, CrNic, CrPic, 
or CrNGCG had intermediate DP. There was no (P >  .20) main effect of Cr 
supplementation on carcass traits.
Sem m  Mfttahnlitea and Horm ones
Day 21. In pigs that had not had access to feed for 20 h, serum glucose was 
lower (P <  .05) in pigs fed Cr (main effect). Serum glucose was lower (P <  .05) 
in pigs fed CrNic, CrNGCG, or CrPic-2 than in pigs fed the basal diet; pigs fed 
other Cr sources had intermediate serum glucose concentrations (Table 3.3). Serum
Table 3.2. Effect of dietary chromium source on growth performance and carcass characteristics of growing-finishing pigs*
Chromium source ___________________________________ Pooled
Criterion Basal Chloride Acetate Oxalate Nicotinate CrPic-1 Complex CrPic-2 SEM
Grower phase
ADG, kg .81b .70* .74°* .71* .76** .75** .77* .77* .02
ADFI, kg 2.34 2.31 2.03 2.02 2.16 2.06 2.28 2.11 .12
Gain/feed .348* .307 .368b .354b .354b .366" .340* .365" .015
Finisher phase
ADG, kg .82* .89* * 00 °s
r
.81c .89* .88* .90* .91" .03
ADFI, kg 3.10* 3.49" 3.09* 2.89* 3.29** 3.18** 3.40* 3.39* .09
Gain/feed .263 .256 .284 .280 .272 .277 .265 .270 .011
Overall
ADG, kg .81* .79* .81* .76* .82b .81* .84" .84" .02
ADFI, kg 2.69** 2.87b 2.53* 2.44* 2.69** .261** 2.84" 2.73* .07
Gain/feed .301* .276* .319* .311b .3Q5b .312” .295* .307" .009
Carcass characteristics
LMA, cm2 29.6 30.4 30.1 31.2 29.3 29.9 29.4 29.9 .8
TRF, cm 3.0 3.0 2.9 2.9 3.2 2.9 3.1 2.9 .1
PM, % 45.2 45.9 46.0 46.8 44.6 45.9 44.7 45.5 .7
DP, % 81.1* 81.3b 80.2* 80.2* 80.7* 80.3* 80.5* 80.9* .4
'Data are means of four replicates of four pigs per replicate; average initial BW = 18.1 kg. The pigs were fed a com-soybean 
meal diet without (Basal) or with 200 ftg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate 
(CrPic-1 ;USDA synthesized), Cr nicotmate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source); 
LMA=longissimus muscle area, TRF=tenth rib fat thickness, PM=percentage of muscling, DP=dressing percentage.
**Means in the same row with uncommon superscripts differ. P < .05.
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glucose was not different (P > .05) between treatments in samples collected 2 h 
postfeeding. Serum NEFA levels were not different (P >  .05) between treatments 
for pigs that had not had access to feed for 20 h. However, 2-h postfeeding serum 
NEFA levels were lower (P <  .05) in pigs fed CrPic-1 than pigs fed CrCl. Other 
treatment diets resulted in intermediate serum NEFA levels. Serum cholesterol was 
not affected (P >  .05) by dietary treatment in pigs that had not had access to feed 
for 20 h (Table 3.4). However, 2 h postfeeding serum cholesterol was less 
(P <  .05) in pigs fed CrNGCG than in pigs fed CrCl, CrAc, or CrPic-1; other 
treatments resulted in intermediate cholesterol concentrations. Seium biacylglycerol 
concentrations for pigs that had not had access to feed for 20 h were lower 
(P <  .05) in pigs fed CrNic, CrNGCG, or CrPic-2 than pigs fed CrOx; pigs fed 
other dietary treatments had intermediate serum triacylglycerol concentrations.
Serum urea N, insulin, and GH concentrations were not different (P >  .05) between 
dietary treatments for both the 20 h without access to feed and 2 h postfeeding 
samples. In addition, there was no main effect of Cr (P >  . 10) on any serum 
metabolite (except glucose) or hormone on Day 21.
Day 77. In pigs that had not had access to feed for 20 h, serum NEFA 
concentrations were lower (P <  .09) in pigs fed Cr (main effect). Serum NEFA 
concentrations were lower (P <  .05) in pigs fed CrPic-2 than pigs fed the basal diet 
(Table 3.3). All other dietary treatments resulted in intermediate NEFA 
concentrations. For the 2 h postfeeding blood samples, serum NEFA concentrations
I
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Table 3.3. Effect o f dietary chromium source on serum glucose, NEFA, insulin, and growth hormone concentrations in growing-
finishing pigs*_____________________________________________________________________________________________
Chromium source Pooled
Criterion___________ Basal Chloride Acetate Oxalate Nicotinate CrPic-1 Complex CrPic-2 SEM
Glucose, mmol/L 
Day 21
Unfed 4.4b 4.2** 4.3* 4.3* 4.0® 4.1* 4.0® 4.0® .1
Fed 9.7 9.5 10.5 10.8 11.3 11.2 10.7 9.8 .8
Day 77 
Unfed 4.1 4.2 4.2 4.3 4.3 4.1 4.1 4.3 .2
Fed 6.0 5.6 5.6 5.6 5.7 5.9 5.7 5.7 .4
NEFA, mEq/L 
Day 21
Unfed 1.050 .944 .883 .986 1.060 1.036 1.034 .984 .065
Fed 
Day 77
.173* .170* .194* .199* .183* .160b .165* .167* .013
Unfed .669b .521* .441* .625* .459* .581* .539* .433® .080
Fed
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Unfed .49 .56 .28 .60 .10 .28 .31 .16 .20
Fed 64.0 53.1 43.6 52.6 56.0 61.7 58.7 52.4 9.7
Day 77 
Unfed 1.93* 1.84e 2.34* 2.05* 2.10* 2.66* 3.01* 4.20* .77
Fed 32.7 33.4 25.9 27.7 44.1 44.8 39.2 27.6 9.2
Growth hormone, ng/tnL 
Day 21
Unfed 5.2 3.5 6.6 4.3 5.0 4.5 4.4 4.6 1.1
Fed 4.7 4.5 4.7 4.4 3.8 4.4 3.8 3.8 .8
Day 77 
Unfed 1.5 1.2 1.0 2.4 .7 1.9 1.1 .6 .6
Fed 1.2 2.3 2.3 2.2 1.5 2.5 2.6 1.6 .7
’Data are means of four replicates with four pigs per replicate; average initial BW = 18.11$. The pigs were fed a com-soybean 
meal diet without (Basal) or with 200 pg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate 
(CrPic-l;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source). 
b,cMeans in the same row with uncommon superscripts differ, P < .05.
to
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Table 3.4. Effect o f dietary chromium source on serum urea nitrogen, cholesterol, and triacylglycerol concentrations of growing- 
finishing pigs*_______________________________________ _ ___________________________________________________
Chromium source   Pooled
Criterion Basal Chloride Acetate Oxalate Nicotinate CrPic-1 Complex CrPic-2 SEM
Urea nitrogen, mmol/L 
Day 21
Unfed 10.6 10.4 9.8 10.0 9.7 9.1 9.5 10.0 .5
Fed 9.8 9.8 9.9 9.9 9.8 9.9 9.4 9.8 .5
Day 77
Unfed 8.6* * 11.6* 10.0* 9.6* 8.8* 8.9* 8.9* 7.6s 1.0
Fed 10.3 12.4 10.8 10.1 10.0 10.1 10.6 8.9 1.2
Cholesterol, mmol/L 
Day 21
Unfed 2.8 2.9 2.9 2.9 2.7 2.9 2.7 2.8 .1
Fed 2.9*“ 3.1* 2.9* 2.8* 3.0* 2.7* 2.9* .1
Day 77
Unfed 2.5* 2.5* 2.7* 2.4* 2.5* 2.6* 2.5* 2.6* * *
Fed 2.7 2.7 2.6 2.6 2.5 2.7 2.6 2.7 .1
Triacylglycerol, mg/dL 
Day 21
Unfed 98.6 99.8* 102.5* 139.5* 82.8* 103.2* 90.0* 91.8* 15.1
Fed 59.1 53.6 71.4 59.3 66.2 72.1 53.5 63.7 8.0
Day 77
Unfed 29.3 36.6 38.3 39.5 32.8 37.8 38.7 27.9 4.7
Fed 28.6 32.4 27.8 31.6 24.6 30.9 31.7 24.3 2.9
(table con’d)
D ata are means of four replicates with four pigs per replicate; average initial BW = 18.1 kg. The pigs were fed a com-soybean 
meal diet without (Basal) or with 200 pg Cr/kg diet as Cr chloride, Cr acetate, Cr oxalate, Cr nicotinate, Cr tripicolinate 
(CrPic-1;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr tripicolinate (CrPic-2; Commercial source). 
*,cMeans in the same row with uncommon superscripts differ, P  <  .05.
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were lower (P <  .05) in pigs fed CrNic or CrNGCG than in pigs fed CiCJ or 
CrPic-2 forms; other dietary treatments resulted in intermediate NEFA 
concentrations. In pigs that had not had access to feed for 20 h, serum insulin 
concentrations were greater (P <  .05) in pigs fed CrPic-2 than in pigs fed CrCl; 
other dietary treatments resulted in intermediate serum insulin concentrations. In 
pigs that had not had access to feed for 20 h, pigs fed CrPic-2 had lower serum urea 
N concentrations than in pigs fed CrCl. All other dietary treatments resulted in 
intermediate serum urea N concentrations for the 20 h without access to feed and no 
differences (P >  .05) were observed between treatments for the 2 h postfeeding 
samples. In pigs that had not had access to feed for 20 h, plasma cholesterol was 
lower (P <  .05) in pigs fed CrOx than in pigs fed CrAc. In the 2 h postfeeding 
samples, no differences (P >  .05) between treatments were observed. Serum 
glucose, GH, and triacylglycerol concentrations were not affected (P > .05) by 
dietary treatments in either the 20 h without access to feed or 2 h postfeeding 
samples. There was no main effect of Cr (P >  . 10) on any serum metabolite 
(except NEFA) or hormone on Day 77.
Tissue Minerals
Chromium. Chromium supplementation (basal diet vs all Cr diets) increased 
heart (P <  .10), kidney (P <  .11), liver (P <  .03), and pancreas (P <  .09) Cr 
concentrations but not (P >  . 10) longissimus muscle Cr concentration (Table 3.5). 
Heart Cr concentration was greater (P <  . 10) in pigs fed CrOx compared with pigs
Table 3.5. Effect of dietary chromium source on tissue chromium, copper, zinc, and iron concentrations of pigs*
Chromium source____________________________________  Pooled
Criterion Basal Chloride Acetate Oxalate Nicotinate CrPic-1 Complex CrPic-2 SEB
Chromium, ng/g dry 
Heart
tissue
8.4® 18.7** 21.9" 9.2* 16.3** 19.8* 11.8*® 3.7
Kidney 9.7* 14.9* 77.7b 50.4* 35.3* 37.8* 10.4* 42.2** 14.4
Liver 8.6* 17.1* 35.0> '34/3* 13.2* 20.4® 9.3* 19.2* 4.1
Pancreas 2.6* 29.6b 1.8® 4.1®* 12.2* 8.3®* 3.7®* 17.6® 3.7
Longissimus muscle 2.2 6.4 4.8 4.1 2.6 5.0 6.8 2.5 2.1
Copper, Â g/g dry tissue
Heart 20.1* 19.6^ 20.2* 19.8* 20.4b 19.7* 19.8* 19.1® .5
Kidney 19.9 19.7 20.6 20.6 19.9 23.6 19.5 18.3 2.0
Liver 25.6 21.2 22.4 21.0 24.6 21.6 22.0 20.5 2.0
Pancreas 4.5* 4.8* 4.6* 4.9b 3.9® 4.4* 4.3* 4.4* .4
Longissimus muscle 1.8 1.8 1.7 2.0 1.8 1.9 1.7 2.1 .2
Zinc, /^g/g dry tissue
Heart 86.0* 89.2* 85.2® 87.2* 92.4b 90.0* 84.5® 83.9® 2.6
Kidney 102.5 100.8 103,9 102.2 99.7 109.2 102.6 93.9 8.2
Liver 271.4b 225.3* 266.8* 241.8* 210.7* 236.6* 205.0* 190.8® 29.8
Pancreas 133.3b 129.9b 146.3* 130.2* 82.7® 138.6® 105.3* 110.8* 17.8
Longissimus muscle 44.0* 44.4* 49.4b 46.3* 48.1* 47.1* 47.3* 42.6® 2.4
(table con’d)
Iron, £tg/g dry tissue
Heart 199.0"* 205.0“ 206.8"* 199.4"* 208.2"* 193.5* 212.3"* 215.8" 7.2
Kidney 171.3d 200.31* 172.8" 180.7®" 210.8" 181.8*" 171.9" 206.8"* 9.9
Liver 654.9bed 601.8W 781.0* 556.8®" 775.3" 668.1"®" 516.2" 721.7*“ 73.8
Pancreas 39.1“ 47.6“ 42.4"* 38.9"® 51.5" 47.7"* 35.6* 48.1" 5.6
Longissimus muscle 14.8 14.7 14.4 16.0 14.9 14.8 13.0 15.4 1.5
D ata are means of four (CrCl and CrPic-2) or two oreplicates (all other sources) with two pigs per replicate; average initial BW = 
18. i  kg. The pigs were fed a com-soybean meal diet without (Basal) or with 200 fig Cr/kg diet as Cr chloride, Cr acetate, Cr 
oxalate, Cr nioodnate, Cr tripicolinate (CrPic-l;USDA synthesized), Cr nicotinate-glycine-cysteine-glutamate complex, or Cr 
tripicolinate (CrPic-2; Commercial source).
MA*Meant in the same row with uncommon superscripts differ, P <  .10.
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fed the basal diet* CrNic, or CrPic-2. Kidney Cr concentration was greater (P <
. 10) in pigs fed CrAc than in pigs fed the basal diet, CrCl, CrNic, CrPic-1, or 
CrNGCG. liv e r Cr concentration was not different (P >  .10) between the pigs fed 
CrAc or CrOx and both of these forms of Cr resulted in greater (P <  , 10) liver Cr 
concentration than in pigs fed the basal diet or the other Cr sources. Pancreas Cr 
concentration was greater (P <  . 10) in pigs fed CrCl than in pigs fed the other Cr 
sources. Longissimus muscle Cr concentration was not affected (P > . 10) by dietary 
treatment.
Copper. Overall Cr supplementation (basal diet vs all Cr diets) did not affect 
(P >  .10) tissue copper concentrations. Heart copper concentrations were greater 
(P <  . 10) in pigs fed CrNic than in pigs fed CrPic-2. Pancreas copper 
concentration was greater (P <  .10) in pigs fed CrOx than in pigs fed CrNic. 
Kidney, liver, and longissimus muscle copper concentrations were not affected 
(P > . 10) by dietary treatment.
Zinc. Chromium supplementation (basal diet vs all Cr diets) did not affect 
(P >  . 10) heart, kidney, liver, pancreas, or longissimus muscle zinc concentrations. 
Heart zinc concentration was greater (P <  . 10) in pigs fed CrNic than in pigs fed 
CrAc, CrNGCG, or CrPic-2. liv e r zinc was lower (P <  .10) in pigs fed CrNic or 
CrPic-2 than in pigs fed CrAc, CrNGCG, or CrPic-2. Longissimus muscle zinc 
concentration was greater (P <  .10) in pigs fed CrAc than in pigs fed CrPic-2. 
Pancreas zinc concentration was lower (P <  . 10) in pigs fed CrNic than in pigs fed
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the basal diet, CrCl, CrAc, or CrPic-1. Kidney zinc concentration was not different 
(P >  . 10) among dietary treatments.
. Icon. Heart iron concentration was greater (P <  . 10) in pigs fed CrPic-2 than 
in pigs fed CrPic-1. Kidney iron concentration was greater (P <  . 10) in pigs fed 
CrCl, CrNic, or CrPic-2 than in pigs fed the basal diet, CrAc, or CrNGCG. liver 
iron concentration was greater (P <  .10) in pigs fed CrAc or CrNic than in pigs fed 
CrOx or CrNGCG. Pancreas iron concentration was greater (P <  .10) in pigs fed 
CrNic or CrPic-2 than in pigs fed CrNGCG. Longissimus muscle iron 
concentration was not affected (P >  .10) by dietary treatments. In addition, there 




In general the supplementation of diets for pigs with various Cr sources had 
minimal effects on gain, feed intake, and gain:feed. For example, in the grower 
phase, the decrease in growth due to CrCl, CrAc, and CrOx was overcome in the 
finisher phase (with the exception o f CrCl). It appeared that the overall decrease in 
growth (the basal diet vs all Cr sources) during the grower phase traded to be 
compensated for during the finisher phase.
The effect of different Cr sources on growth performance of animals 
(especially domestic livestock) has not been evaluated to any extent. Most studies
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have evaluated either CrCl or CrPic. For example, Page et al. (1993b) investigated 
either increasing dietary concentrations of CrPic or individual additions of CrCl, 
picolinic acid, or the combination of CrCl and picolinic acid. In one experiment, 
CrPic decreased ADG and ADFI in a dose dependent manner from 0 to 800 ppb of 
dietary Cr as CrPic (Page et al., 1993b). In another experiment ADG was 
decreased in a cubic manner, although the decrease was primarily at one dietary 
concentration of Cr (100 ppb as CrPic). A third experiment found no effect on 
growth performance o f pigs fed singular additions of either CrCl or picolinic acid or 
the combination of CrCl and picolinic acid. Lindcmann et al. (1995) reported that 
250 and 500 ppb Cr as CrPic tended to reduce ADFI without affecting ADG, 
resulting in an increase in gain:feed. However, Evock-Clover et al. (1993) repoited 
no effect of 300 ppb Cr as CrPic on ADG, ADFI, or gainrfeed. Other authors have 
reported either decreased (Boleman et a l., 1995) or increased (tendency vs CrCl,
P < . 11; Mooney and Cromwell, 1994) growth of pigs due to dietary CrPic 
supplementation. Smith et al. (1994) reported no effect of 200 ppb Cr from CrNic 
on gain, feed intake, or gain:feed.
The conditions under which Cr supplementation results in changes in growth 
performance have not been defined. Some investigators have suggested that "stress” 
is necessary to induce a response to supplemental Cr (Anderson, 1994; Mowat,
1994). We believe that the pigs in the current investigation experienced minimal 
production stress. The pigs were housed in a new facility during the finisher phase
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and were allowed pen space well in excess of that required (Whittemore, 1993). 
Other experiments from this institution (Page et al.( 1993b) were conducted in older 
facilities, which may have been more stressful to the pig. This may explain the 
difference in results obtained from dietary Cr supplementation.
Ca rrass Traits
The lack of an effect of supplemental Cr (especially CrPic) on carcass traits in 
this investigation is hard to explain. Many investigators have reported 
improvements in carcass traits o f pigs fed Cr (Page et a l., 1993a, b; Renteria and 
Cuarrin, 1993; Smith et al., 1994; Lindemann et al., 1995). However, not all 
reports have been positive regarding the effect of supplemental Cr on linear carcass 
measurements. Boleman et al. (1995) reported that supplemental CrPic increased 
TRF when it was fed during the growing and finishing phases but decreased TRF 
when it was fed only during the finishing phase. Mooney and Cromwell (1994) 
reported no effect of dietary Cr as CrCl or CrPic on TRF but an increase in LMA 
due to either CrCl or CrPic supplementation. However, Page et al. (1993a) 
reported no effect o f CrCl on carcass measurements. Boleman et al. (1995) and 
Mooney and Cromwell (1995) both reported that pigs fed supplemental CrPic did 
not have measurable differences in linear carcass measurements (i.e., LMA and 
TRF). However, carcass dissection and chemical analysis revealed that pigs fed 
CrPic had increased carcass lean and decreased carcass fat compared with 
unsupplemented controls. Other investigators also have reported variable responses
38
to dietary Cr supplementation of swine diets. Lindemann et al. (1995) reported no 
effect o f CrPic on carcass traits in one experiment and increased LMA and 
decreased TRF in another experiment. Evock-Clover et al. (1993) reported no 
effect of dietary CrPic on carcass measurements in pigs with or without exogenous 
pituitary porcine somatotropin (ppST) administration. Some investigators have 
postulated that the genetic potential for lean growth may influence the response 
obtained in pig carcass composition (Roger Campbell, Prince Nutrition Conference, 
1993). Pigs with increased potential for lean gain, and thereby less fat, may not be 
as responsive to dietary Cr supplementation. The genotype used in this experiment 
is considerably different than the genotype first used by Page et al. (1993b) at this 
institution. The genetic potential for lean gain of the pigs from the Louisiana State 
University Agricultural Center Swine Unit has continually increased over the years 
and thus may be affecting the responses we are able to obtain in pig carcass 
composition. In addition, as noted previously, this study was conducted in a new 
finishing facility. If stress was responsible for the response to Cr supplementation in 
previous studies, then perhaps these new facilities reduced the amount o f stress to 
which these pigs were exposed. Another proposed reason for a lack of response to 
Cr is that over time we may have contaminated our feed mixing equipment at the 
Louisiana State University Agricultural Center Swine Unit. We do not have 
evidence to support this hypothesis; the diets have not been analyzed for Cr content. 
More importantly, some researchers believe that as Cr stores of a population (i.e., a
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herd) are repleted (assuming they were depleted initially) then it may not be possible 
to demonstrate a response to supplemental Cr (Merlin Lindemann, personal 
communication). This hypothesis is in line with the belief that Cr is acting as an 
essential nutrient and not as a pharmacological agent.
Serum Mfttnhnlites and Hormones
After 21 days on the treatments CrNic, CrNGCG, and CrPic-2 reduced serum 
glucose. In fact there was a main effect of Cr in reducing serum glucose (the basal 
diet vs all Cr sources). However, none of the Cr sources affected serum glucose 
after 77 days on the experimental diets. Most reports o f reduced serum glucose 
levels have been in the early stage of Cr supplementation. For example, Kitchalong 
et al. (1995) reported a  reduced response to an IVGTT for sheep fed CrPic during 
the first 2 wk of an experiment but lack of a response after 10 wk of 
supplementation. Other investigators have reported increased glucose clearance 
rates due to CrPic supplementation (Bunting et al., 1994; Amoikon et a l., 1995) in 
relatively short-term experiments. Page et al. (1993b) reported no difference in 
serum glucose of pigs from a single blood sample taken 3 h after initiation of 
feeding after 73 d of CrPic supplementation. However, Evock-Clover et al. (1993) 
reported that CrPic supplementation “normalized" plasma glucose concentrations in 
pigs injected with ppST in an experiment of relatively shorter duration (39 to 50 d). 
Lindemann et al. (1995) reported a  decrease in the insulin:glucose ratio o f sows fed 
CrPic,
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Hie variable response of serum cholesterol and NEFA concentrations to 
different Cr compounds was not surprising. These two metabolites have been 
reported to be decreased (cholesterol, Page et a l., 1993; NEFA, Amoikon et al.,
1995), increased (cholesterol, Evock-Clover et al., 1993; Amoikon et a l., 1995), or 
unchanged (cholesterol, Lindemann et al., 1995) in pigs fed supplemental CrPic. 
However, the reduction in serum NEFA from CrPic-1 supplementation but not 
CrPic-2 is surprising since these were identical chemical compounds differing only 
in their source.
The variability in other metabolites and hormones also has been reported in 
pigs (Evock-Clover et a l., 1993; Page et al., 1993; Lindemann et a l., 1995), sheep 
(Gentry et a l., 1995; Kitchalong et a l., 1995; Ward et a l., 1995) and cattle (Bunting 
et a l., 1994; DePew et a l., 1995). The reason(s) for these variable responses is not 
known.
Tigsiift Minerals
The lack of an increase in muscle Cr content from supplemental dietary Cr is 
in agreement with other research (Anderson et al., 1989, 1994). Increased tissue 
chromium concentrations could become a regulatory issue. However, because most 
Americans and others from highly developed countries do not consume the 
recommended daily safe and adequate intake o f Cr (Anderson, 1989), some 
scientists consider increased Cr content o f animal protein as a  means of 
supplementation of human diets with Cr an acceptable method of increasing Cr
intake of the population (Anderson et a l., 1989). Nonetheless, mineral deposition 
data are scarce and necessary. Overall, organic sources o f Cr resulted in higher 
tissue Cr levels than the basal diet or CrCl. The exception is pancreas Cr. Pancreas 
Cr levels were dramatically higher in pigs fed CrCl than in pigs fed the other dietary 
treatments. Berggren and Flatt (1985) reported endocrine and exocrine pancreas Cr 
concentrations five to sixty-fold higher than liver, kidney, skeletal muscle, cardiac 
muscle, spleen, pituitary, testes and ovaries in rats fed CrCl. While it is generally 
accepted that inorganic sources o f Cr are not absorbed as readily as organic sources 
(Mertz, 1969; Votava et al., 1973), the pancreatic Cr pool does not exchange Cr 
with the blood as rapidly as other tissues (Jain et a l., 1981). Other investigators also 
have reported increased Cr in kidney and liver but not in heart or muscle of pigs fed 
supplemental Cr as CrPic (Anderson et a l., 1994). Anderson et al. (1994) also 
reported no effect of CrPic supplementation on the concentration of zinc and iron in 
muscle tissue o f pigs. Schrauzer et al. (1986) reported that mice fed Cr-rich 
brewer’s yeast had increased Cr levels in the liver and heart. Chromium 
supplementation also increased liver iron and decreased liver zinc concentrations. In 
addition, mice fed Cr-supplemented diets had decreased manganese, iron, copper, 
and zinc concentrations in the heart (Schrauzer et al., 1986).
42
Implications
Chromium addition to swine diets may not result in improvements in body 
composition. Even though absorption and tissue retention of chromium seemed to 
occur in the current investigation, changes in body composition were not observed.
CHAPTER IV
EFFECT OF DIETARY CHROMIUM SOURCE ON GLUCOSE TOLERANCE 
AND INSULIN SENSITIVITY IN GROWING PIGS
Introduction
Chromium is most often associated with carbohydrate metabolism, being 
necessary for insulin function for glucose uptake by cells (Anderson, 1985). 
Chromium deficiency leads to glucose intolerance, and Cr supplementation of the 
diets o f elderly humans has resulted in improved glucose tolerance (Mertz, 1993). 
Total parenteral nutrition patients also have been reported to have reduced diabetic 
signs when given supplemental Cr (Jeejeebhoy et al., 1977; Brown et al., 1986).
Steele et al. (1977) reported that a synthetic glucose tolerance factor containing 
Cr enhanced the hypoglycemic action of insulin in pigs. Dietary Cr as Cr 
tripicolinate (CrPic) also has been shown to increase glucose disappearance rate (k) 
and decrease glucose half-life (TI/a) in calves (Bunting et a l., 1994) and pigs 
(Amoikon et al., 1995). In pigs, CrPic has been shown to increase loin eye area 
and decrease fat thickness (Lindemann et a l., 1993; Page et a l., 1993a,b; Renteria 
and Cuardn, 1993), and to increase the rate of lean and decrease the rate of fat 
deposition (Mooney and Cromwell, 1993; Boleman et al., 1994). However, Cr 
chloride hexahydrate (CrCl) did not affect carcass traits of pigs (Page et al.,
1993a,b). Smith et al. (1994) reported that Cr nicotinate (CrNic) decreased backfat 
thickness but did not affect loin eye area of pigs. Thus, the form of Cr (inorganic or
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organic) also may affect the glucose responses that have been reported for livestock 
species. Therefore, these experiments were conducted to determine the effect of Cr 
as CrCl, CrNic, or CrPic on glucose tolerance and insulin sensitivity in growing 
pigs.
M aterials and Methods
Animals anH nifttary TreatmpJits
Two identical trials were conducted. Crossbred (Yorkshire x Landracc 
females bred to Hampshire boars) barrow pigs were used [Trial 1, n=36, avg. 
initial body weight (BW )=20.2 kg; Trial 2, n=36, avg. initial BW =23.0 kg]. The 
pigs were allotted to treatment on the basis o f weight in a randomized complete 
block design; ancestry was equalized across treatments. Each treatment was 
replicated three times in each trial with three pigs per replicate. Three pens of three 
pigs each per trial were fed a control diet without supplemental Cr. Trial 1 was 
conducted from mid-November through mid-December 1994. Trial 2 was 
conducted from mid-January through mid-February 1995.
The pigs were fed a com-soybean meal basal diet (Table 4.1) formulated to 
provide 120% of the NRC (1988) lysine requirement. The dietary treatments 
consisted of supplementing the basal diet with either 0 or 400 /tg Cr/kg diet from 
CrCl (Sigma Chemical Co., St. Louis, MO), CrNic (provided by Dr. R. A. 
Anderson, USDA, Beltsville, MD), or CrPic (CHROMAX™, Prince Agri Products,
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Table 4.1. Composition of the basal diet* as-fed basis
Item %
Com 73.01





Trace mineral premixb .05
‘Provided the following per kilogram of diet: riboflavin, 4.4 mg; d-pantothenic acid, 
22 mg; niacin, 22 mg; vitamin Bw, 22 ^g; d-biotin, 220 fig; choline chloride, 440 
mg; vitamin A, 4400IU; vitamin D}, 440IU; vitamin E, 11IU; menadione
dimethylpyrimidinol bisulfite, .25 mg; Se, .1 mg.
‘’Provided the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg; 
Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.
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Quincy, IL). The pigs (three replicates of three pigs each) were allowed to consume 
the treatment diets on an ad iihihim basis during the first 21 d of the trials during 
which time the pigs were group-penned in 1.8-m x 2.4-m pens in an enclosed 
facility with totally slatted floors. After this growth period, five pigs per treatment 
were randomly selected and moved into .6-m x 1.2-m plastic metabolism crates and 
penned individually. H ie pigs were fed (feed mixed with water) twice daily an 
amount approximating one-half their ad Iihihim intake. Growth performance data 
were collected for the period prior to placing the pigs in the metabolism crates. 
(Tathftterizatinn
After approximately 5 d in the metabolism crates, the pigs were anesthetized 
i.m . with Telazol® (4.4 mg/kg BW, contains 2.2 mg tiletamine/kg BW as tiletamine 
HC1 and 2.2 mg zolazepam/kg BW as zolazepam HC1; Fort Dodge Laboratories, 
Inc., Fort Dodge, IA) plus Rompun® (4.4 mg xylazine/kg BW; Miles Inc., Shawnee 
Mission, KS). A 12-gauge trocar was inserted into the right jugular fossa. A 
catheter (Norton Tygon tubing No. AAQ04127; 1.02 mm i.d ., 1.78 mm o.d.;
Fisher Scientific, Pittsburgh, PA) was passed through the trocar and into the jugular 
vein. The catheter was filled with a 6% sodium citrate solution, sutured, and glued 
to the skin of the pigs at the point where the catheter exited the skin, routed to the 
top o f the neck and held in place with surgical and duct tape. The total length of the 
catheter was approximately 120 cm; approximately 10 to IS cm of catheter was 
inserted inside the jugular fossa, 40 cm was required to route the catheter to the top
47
of the neck, and approximately 70 cm of catheter was stored in a small pouch at the 
top of the neck for ease in blood collection.
Metabolic  Challenges
Two to three d after catheterization, an intravenous glucose tolerance test 
(TVGTT) was conducted followed 3 h later by an intravenous insulin challenge test 
(IVICT) as outlined by Bunting et al. (1994). In both experiments, feed was 
withheld for 15 to 18 h prior to the rVGTT. In brief, for the IVGTT and IVICT, 
respectively, glucose (500 mg/kg BW) and insulin [. 1 U of crystalline porcine 
insulin (Sigma #I-3505)/kg BW administered in a .9% NaCl solution containing .2% 
bovine serum albumin (Fraction V Powder, Cat# 810-1018, Lot#A090767, Grand 
Isle Biological Co., Grand Isle, NY) were administered via the jugular vein catheter 
as bolus doses. Blood samples were collected via syringe and placed into 7-mL 
tubes containing 17.5 mg sodium fluoride and 14.0 mg potassium oxaJate 
(Monoject®, Sherwood Medical, St. Louis, MO) at -1 0 ,0 ,5 , 15, 30, 45, 60,90, 
and 120 min relative to dosing for the IVGTT. For the IVICT, additional samples 
were taken at 10, 20, 25, 150, 180, 210, and 240 min. Glucose k (%/min) and Tll7 
(min) were calculated between 15 and 30 min for the IVGTT, and between 0 and 30 
min for the IVICT as a modification of the method outlined by Kaneko (1989). 




Blood metabolites and insulin were measured in plasma from the 0 min blood 
samples collected before the IVGTT test. All IVGTT and IVICT samples were 
analyzed for insulin and glucose concentrations. Plasma was analyzed for glucose 
(Sigma, 1990) and cholesterol (Sigma, 1989) concentrations, using 
spectrophotometric procedures outlined in commercially-available kits (Sigma 
Chemical Co.). Plasma urea N concentrations were determined 
spectrophotometrically using the urease procedure outlined by Fernandez et al. 
(1988), and plasma NEFA concentrations were determined using a commercial 
enzymatic procedure (NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA, 
Inc., Richmond, VA). All samples were assayed in duplicate and measurements 
resulting in errors greater than 5% were re-analyzed.
Plasma insulin was assayed by the RIA method of Amoikon et al. (1995). 
Guinea pig anti-bovine insulin antiserum (Code No. 65-101, Lot No. GP616; ICN 
ImmunoBiologicals, Lisle, IL) was used at a  1:60,000 final dilution. Purified 
porcine insulin (26.1 jiU/ng; Sigma Chemical Co.) and bovine 12SI-insulin (ICN 
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand, 
respectively. Sheep anti-guinea pig antiserum produced in our laboratory was used 
at a 1:4 dilution as the precipitating antibody. The intraassay and interassay CV for
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the insulin RIA as determined by pooled bovine plasma samples were 14% and 
13%, respectively.
Statistical Analy.w
Data from these experiments were analyzed by ANOVA (Steel and Torrie, 
1980) using the GLM procedure of SAS (1985). The growth performance data were 
analyzed as a randomized complete block design with initial weight as blocks and 
the pen o f pigs was the experimental unit. The metabolite and insulin data were 
analyzed as a completely random design and the individual pig was the experimental 
unit. Common criteria for Trials 1 and 2 were found not to contain trial by 
treatment interactions, therefore the data were pooled for statistical analyses and 
presentation.
Results and Discussion
Average daily gain (ADG), average daily feed intake (ADFI) and gain/feed 
were not affected (P >  .10) by dietary treatment (Table 4.2). These results are in 
agreement with other research conducted using pigs (Amoikon et al., 1995; Evock- 
Clover et al., 1993; Lindemann et a l., 1993; Page et al., 1993a,b; Renteria and 
Cuardn, 1993), lambs (Kitchalong et al., 1995), and calves (Bunting et al., 1994).
Plasma cholesterol, NEFA, urea N, and insulin were not affected (P >  .05) 
by treatment (Table 4.3). Reduced levels o f circulating total cholesterol have been 
reported in pigs (Page et a l., 1993a) and calves (Bunting et al., 1994) fed CrPic. 
However, Evock-Clover et al. (1993) reported that supplemental dietary CrPic
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Table 4.2. Effect o f dietary chromium source on daily gain, feed intake, and
gain/feed in growing barrows (Trial 1 and Trial 2 combined)*
Criterion
Treatment Pooled
SEMControl CrCl CrNic CrPic
ADG, kg .84 .83 .86 .84 .02
ADFI, kg 1.98 2.01 1.98 2.00 .06
Gain/feed .43 .41 .44 .42 .01
■Data are means of six replicates with three pigs per replicate; avg. initial BW = 
21.6 kg (Trial 1, 20.2; Trial 2, 23.0). The pigs were fed a com-soybean meal diet 
without (Control) or with 400 /ig Cr/kg diet as Cr chloride hexahydrate (CrCl), Cr 
nicotinate (CrNic), or Cr tripicolinate (CrPic). The growth trial period was 21 d.
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Table 4.3. Effect of dietary chromium source on plasma metabolites and hormones
in growing barrows*
Treatment Pooled
Criterion Control CrCl CrNic CrPic SD
Glucose, mmol/L 4.72* (11) 4.56' (9) S.Otf (11) 4.77* (8) .39
Cholesterol, mmol/L 2.31 (11) 2.38 (9) 2.31 (11) 2.36(11) .34
Urea N, mmol/L 6.04 (11) 5.81 (9) 5.39 (11) 5.97 (8) 1.28
NEFA, mEq/L •59 (9) .61 (9) .57 (9) •71 (5) .29
Insulin, /zU/mL 4.18(11) 4.13(9) 4.39(11) 4.77 (8) 2.46
*The pigs were fed a com-soybean meal diet without (Control) or with 400 ftg Cr as 
Cr chloride hexahydrate (CrCl), Cr nicotinate (CrNic), or Cr tripicolinate 
(CrPic)/kg diet. The number of barrows is shown in parentheses. Plasma samples 
were collected after 15 to 18 h without feed.
‘“Means within a row without a common superscript differ, P <  .05.
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increased total cholesterol and high-density lipoprotein(HDL)-cholesterol in pigs. 
Amoikon et al. (1995) also reported increased total cholesterol and decreased 
NEFAin pigs fed CrPic. Chromium supplementation in humans also has yielded 
variable effects on cholesterol components (Riales and Albrink, 1981; Anderson et 
al.* 1983; Evans, 1989; Lefavi e ta l., 1993). Chromium compounds have been 
reported to lower serum triacylglycerol (Ranhotra and Gelrotb, 1986) and NEFA 
(Mirsky, 1993) in rats.
During the IVGTT, glucose k and glucose Tl/2 were not affected (P >  . 10) by 
treatment (Table 4.4). In a similar manner, during the IVICT, glucose k and 
glucose TI/2 were not affected (P >  .10) by dietary treatment. The response curves 
depicting mean glucose concentrations over time during the IVGTT and I VICT are 
shown in Figures 4.1 and 4.3, respectively. The response curves depicting mean 
insulin concentrations over time during the IVGTT and IVICT are shown in Figures 
4.2 and 4.4, respectively. Amoikon et al. (1995) reported that pigs fed 200 jug Cr 
as CrPic per kg diet had increased glucose clearance and decreased glucose half-life 
during IVGTT. The reason(s) for the lack of agreement between the data of 
Amoikon ct al. (1995) and the current experiment are not known. During the 
IVICT (Table 4.5), insulin k and insulin T,^ were not affected (P >  .10) by dietary 
treatment. Amoikon et al. (1995) reported similar findings in pigs fed CrPic.
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Table 4.4. Effect of dietary chromium source on glucose kinetics in growing
barrows*_________________________________________________________
Treatment Pooled
Criterion Control CrCl CrNic CrPic SD
Intravenous Glucose Tolerance Test (IVGTT), 15-30 min
Clearance, %/min 3.82(11) 4.02 (9) 3.40 (11) 3.05 (8) 1.28
Half-life, min 20.32(11) 19.23 (9) 23.60(11) 24.80 (8) 7.33
Intravenous Insulin Challenge Test (IVICT), 0-30 min
Clearance, %/min 2.84 (11) 2.71 (9) 2.64 (11) 2.25 (8) .81
Half-life, min 27.27(11) 27.82 (9) 29.31 (11) 33.73 (8) 10.45
“The pigs were fed a com-soybean meal diet without (Control) or with 400 ng Cr as 
Cr chloride hexahydrate (CrCl), Cr nicoiinate (CrNic), or Cr tripicolinate 
(CrPic)/kg diet. All data are means of individually fed pigs. Number of barrows is 
shown in parentheses.
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Table 4.5. Effect of dietary chromium source on insulin kinetics in growing
barrows*________________________________________________________
Treatment Pooled
Criterion Control CrCl CrNic CrPic SD
Intravenous Glucose Tolerance Test (IVGTT), 15-30 min 
Clearance, %/min 7.72(11) 9.05(9) 6.57(9) 





Intravenous Insulin Challenge Test (IVICT), 15-30 min
Clearance, %/min 6.45(11) 6.77(9) 6.95 (11) 5.12(8) 2.44
Half-life, min 11.74(11) 10.73(9) 11.09(11) 17.76(8) 5.29
T he pigs were fed a com-soybean meal diet without (Control) or with 400 /*g Cr as 
Cr chloride hexahydrate (CrCl), Cr nicotinate (CrNic), or Cr tripicolinate 
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Figure 4.1. Effect of dietary chromium on glucose tolerance in pigs during an 
intravenous glucose tolerance test. Pigs were fed a com-soybean meal control diet 
without ( • )  or with 400 fig Cr as CrCl (■), CrNic (A ), or CrPic (T )/kg diet. For 
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Figure 4.2. Effect o f dietary chromium on insulin clearance in pigs during an 
intravenous glucose tolerance test. Pigs were fed a com-soybean meal control diet 
without ( • )  or with 400 fig Cr as CrCl (■), CrNic (A ), or CrPic (Y)/kg diet. For 
glucose insulin disappearance rate: pooled SD =  4.35; and for insulin half-life; 
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Figure 4.3. Effect o f dietary chromium on glucose clearance in pigs during an 
intravenous insulin challenge test. Pigs were fed a com-soybean meal control diet 
without ( • )  or with 400 /*g Cr as CrCl (■), CrNic (A ), or CrPic (T )/kg diet. For 
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Figure 4.4. Effect of dietary chromium on insulin clearance in pigs during an 
intravenous insulin challenge test. Pigs were fed a com-soybean meal control diet 
without ( • )  or with 400 /xg Cr as CrCI (■), CrNic (A ), or CrPic (▼)/kg diet. For 
glucose insulin disappearance rate: pooled SD — 2.44; and for insulin half-life; 
pooled SD = 5.29.
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Steele et al. (1977) demonstrated that Cr-containing GTF increases insulin 
sensitivity in pigs. These authors concluded that GTF was biologically active in 
swine and that it potentiated the insulin-insulin receptor interaction. Beneficial 
effects of Cr-rich yeast on glucose tolerance and insulin sensitivity in elderly people 
have been reported (Offenbacher and Pi-Sunyer, 1980). Riales and Albrink (1981) 
reported that supplementation with Cr as CrClj‘6H20  improved insulin sensitivity in 
subjects with insulin resistance, but in not subjects with normal glucose tolerance. 
Abraham et al. (1992) also has reported no effect of dietary Cr supplementation (as 
CrCI) on the glucose status o f patieuts with or without non-insulin-dependent 
diabetes. However, the most prominent data regarding Cr supplementation is (hat 
glucose intolerance has been associated with Cr deficiency (Schioedcr, 1966; 
Stoecker and Oladut, 1985; Anderson, 1987). Chromium supplementation has been 
found to be essential for normal glycemia and insulin function in human patients 
receiving long-term total parenteral nutrition (Jeejeebhoy et a l., 1977; Brown et a l., 
1986).
Bunting et al. (1994) reported that Cr as CrPic increased glucose k  in cattle; 
however, both Kitchalong et al. (1995) and Fomea et al. (1994) reported no effect 
o f dietary CrPic on glucose clearance rates in lambs. Evock-Clover et al. (1993) 
reported that dietary CrPic "normalized” plasma glucose and insulin in pigs injected
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with somatotropin. Thus, the conditions which affect the glucose response to Cr 
supplementation remain unknown.
The current study was conducted in the same facilities as those used by 
Amoikon et al. (1995). Thus a reduction in stress due to better facilities as 
hypothesized in the previous chapter of this dissertation is probably not valid in this 
case. However, it is possible that genotypic changes or the Cr status of the pigs at 
the Louisiana Agricultural Center Swine Unit have changed and thus may be 
responsible for the discrepant responses.
Implications
In this report, we have shown that chromium as chromium chloride, chromium 
nicotinate, and chromium tripicolinate did not affect glucose tolerance or insulin 
sensitivity in pigs. These results are not in agreement with other studies in which 
both organic and inorganic sources o f chromium have been used to demonstrate the 
importance o f chromium in insulin sensitivity in humans, pigs, and other animal 
species. The reasons for the discrepant results of chromium supplementation for pigs 
and other livestock species remain unknown. Some speculate that the level of 
environmental stress, genotype differences, or Cr status may account for the 
differences in response to supplemental dietary chromium. The precise conditions 
under which chromium benefits livestock must be characterized if chromium is to be 
recognized as an essential feed additive.
CHAPTER V
INTERACTIVE EFFECTS OF DIETARY CHROMIUM TRIPICOLINATE 
AND CRUDE PROTEIN LEVEL IN GROWING-FINSHING PIGS 
PROVIDED INADEQUATE AND ADEQUATE PEN SPACE: EFFECTS ON 
GROWTH PERFORMANCE, CARCASS CHARACTERISTICS, AND PLASMA
METABOLITES AND HORMONES
Introduction
Page et al. (1993a,b) reported that Cr tripicolinate (CrPic) decreased 10th rib 
backfat thickness and increased longissimus muscle area in pigs. Other authors have 
also reported improvements in body composition of swine from supplemental dietary 
CrPic (Renteria and Cuardn, 1993; Mooney and Cromwell, 1994; Boleman et al., 
1993; Lindcmann et a l., 1995). Our laboratory (Boleman et al., 1995) as well as 
Mooney and Cromwell (1995) has obtained equivocal results in improved linear 
carcass measurements of pigs fed supplemental, dietary Cr. Some investigators have 
suggested that animals have to be under some form of stress to elicit a response to 
Cr supplementation (Anderson, 1994; Mowat, 1994). Recently, we have conducted 
several trials without obvious improvement in the linear carcass measurements in 
response to supplemental Cr (unpublished data, and Ward et a l., 1995; these 
experiments were conducted in new finishing facilities). We hypothesized that the 
production stress the pigs experienced was decreased over that of pigs in earlier 
studies in which responses to Cr supplementation were found. One means of 
subjecting pigs to a chronic production stress would be to reduce the pen space 
allowance per pig. Undemann et al. (1993) reported that the response to
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supplemental dietary Cr may be dependent on the lysine (or CP) content of the diet. 
Therefore, we conducted the following investigation to investigate the interactive 
effects of dietary Cr, CP, and pen space allowance in growing-finishing pigs.
M aterials and Methods 
Animals and n letary  Treatments
Crossbred (Yorkshire x Landrace females bred to Hampshire boars) pigs were 
used [avg. initial body weight (BW )=27.2 kg]. The pigs were allotted to treatment 
on the basis of BW in a randomized complete block design; ancestry was equalized 
across treatments. Each treatment was replicated four times with four pigs per 
replicate pen. Four pens of four pigs each were fed a  control diet without Cr 
supplementation. Sex (two gilts and two barrows) was equalized within pen.
A 2 x  2 X 2 factorial arrangement o f treatments was used. The pigs were fed 
a com-soybean meal basal diet formulated to provide 80 or 120% of the lysine 
requirement (NRC, 1988) during both the grower and finisher phases (Table 5.1). 
The additional dietary factor was two levels o f Cr (none or 400 Mg Cr/kg diet as 
CrPic; Chromax™, Prince Agri Products, Inc., Quincy, IL). The pigs were 
allowed to consume the treatment diets on an adiihitum  basis. The third treatment 
factor was two areas of pen space (mVpig; adequate, .035 BW,(i7 kg, or inadequate, 
.025 BW 67 kg; Whittemore, 1993). The pigs were weighed weekly and pen space 
was adjusted at 10 kg of BW gain increments on an individual pen basis. The pigs 
were penned in a  curtain-sided facility with totally slatted concrete floors. Each pen
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Table S .l. Composition of the basal diets, as-fed basis
Grower Finisher
Percentage of Lysine Requirement
80 120 80 120
Item %
Com 84.12 73.01 89.15 80.27
Soybean meal, 44% CP 13.44 24.74 8.87 17.91
Limestone 1.05 1.06 .99 .99
Dicalcium phosphate .84 .64 .44 .28
Salt .25 .25 .25 .25
Vitamin premix' .25 .25 .25 .25
Trace mineral premixb .05 .05 .05 .05
'Provided the following per kilogram of diet: riboflavin, 4.4 mg; d-pantothenic acid, 
22 mg; niacin, 22 mg; vitamin B)2, 22 n g; d-biotin, 220 u%\ choline chloride, 440 
mg; vitamin A, 4400IU; vitamin I>3. 440 IU; vitamin E, 11 IU; menadione 
dimethylpyrimidinol bisulfite, .25 mg; Se, .1 mg. Treatment diets were fed 
without and with 400 //g Cr as Cr tripicolinate/kg diet.
bProvided the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg; 
Cu, 8.75 mg; I, 1 mg; Ca, 9 mg.
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contained a single-hole feeder and a single nipple waterer. The pen space allowance 
calculations accounted for the space occupied by the feeder. Pigs were switched to 
finisher diets when the average BW of a pen was approximately 55 kg. The pigs 
were removed from the experiment when die average BW of a pen was 
approximately 104 kg. This experiment was conducted from the end of August 
1994 to the first wk of January 1995.
Blnnd Sampling
All pigs were bled via the anterior vena cava following 20 h without access to 
feed and again 2 h postfeeding on d 21 of the experiment. Blood for plasma 
metabolites was placed into 7-mL tubes (Monoject®, Sherwood Medical, St. Louis, 
MO) containing 17.5 mg sodium fluoride and 14.0 mg potassium oxalate. Blood for 
plasma hormones was placed into 7-mL tubes (Monoject®) containing 10.5 mg 
KjEDTA. All blood samples were placed in an ice bath immediately after 
collection. The blood samples were centrifuged for 20 min at 1,600 X g at 4°C. 
Plasma was collected and frozen (-20°C) for later analyses.
P-amass Traits
Pigs were killed via electrical shinning followed by exsanguination at the 
Louisiana State University Agricultural Center Department o f Animal Science Meats 
Laboratory. Hot carcass weights were taken with heads off the carcass and leaf fat 
in the carcass. Longissimus muscle area (LMA) at the 10th rib interface and 10th 
rib fat (TRF) thickness three-fourths the distance from the midline were measured
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after approximately 20 h at 2°C. Longissimus muscle area and TRF were adjusted 
to 104.3 kg (NSIF, 1987), and percentage of muscling (PM) was calculated by 
methods described by the NPPC (1991). Dressing percentage (DP) was calculated 
by dividing hot carcass weight by live BW times 100.
Chemical Analyses
Plasma was analyzed for glucose (Sigma, 1990; Sigma Chemical Co.; St. 
Louis, MO), total cholesterol (Sigma, 1989), and NEFA (NEFA-C Kit, ACS- 
ACOD Method; Wako Chemicals USA, Inc., Richmond, VA) concentrations using 
spectrophotometric procedures outlined in commercially-available kits. Plasma was 
analyzed for urea N by the urease method outlined by Fernandez et al. (1988).
Plasma insulin was assayed by the R1A method of Amoikon et al. (1995). 
Guinea pig anti-bovine insulin antibody (Code No. 65-101, Lot No. GP616; ICN 
ImmunoBiologicals, Lisle, IL) was used at a 1:60,000 final dilution. Purified 
porcine insulin (26.1 /xU/ng; Sigma Chemical Co.) and bovine 123I-insulin (ICN 
Biomedicals, Inc., Costa Mesa, CA) were used as the standard and radioligand, 
respectively. Sheep anti-guinea pig antibody produced in our laboratory was used at 
a 1:4 dilution as the precipitating antibody. The intraassay CV for the insulin RIA 
as determined by a pooled bovine plasma sample was 12.9%.
Plasma GH was measured by a double-antibody RIA technique based on 
antibody (AFP-10318545; A.F. Parlow, Pituitary Hormone and Antisera Center, 
Harbor-UCLA Medical Center, Torrance, CA) against porcine GH (pGH). Highly
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purified pGH was radioiodinated via the chloramine-T method (Greenwood et a l., 
1963; 2.5 fig o f chloramine-T/ftg of GH, 0 °C for 30 s). The antiserum was diluted 
1:150,000 in PBS containing .033 M EDTA, .112% normal rhesus monkey plasma 
(Calbiochem, San Diego, CA), and 33% noninhibitory horse plasma; 300 /iL of this 
solution was used per tube. The horse plasma was added to minimize and to 
stabilize nonspecific binding of radioiodinated pGH to the assay tubes. Antiserum 
(Calbiochem) against rhesus monkey immunoglobulin-G was diluted 1:21 and was 
used at 200 ftL per tube to precipitate the primary antibody. Cross-reactivities of 
other porcine pituitary hormones in the assay were as follows (percentage relative to 
pGH): prolactin, .08; FSH, .12; LH, .001; and thyroid-stimulating hormone, .004 
(A .F. Parlow, personal communication). Inhibition curves produced by serial 
dilutions of porcine sera and pituitary extracts were parallel to those produced by the 
reference standard (USDA-pGH-Bl; National Hormone and Pituitary Agency, 
Baltimore, MD). Sensitivity of the assay averaged . 1 ng; the sample size was 200 
/*L in a typical assay. Intraassay CV in the GH RIA was 7.1%.
Statistical Analyses
Data from this experiment were analyzed by ANOVA (Steel and Torrie, 1980) 
using the GLM procedure of SAS (1985). The data were analyzed as a  randomized 
complete block design with initial BW as the blocking factor. The pen of pigs was 
the experimental unit for all data. Statistical analysis of DP included final BW in
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the model as a covariate. Orthogonal single-degree-of-freedom contrasts were used 
to evaluate the main effects and interactions.
Results
fim wth Performance
During the grower phase of production, pigs fed 120% of the lysine 
requirement had greater (P <  .01) average daily gain (ADG) and gain/feed and 
lower (P <  .03) average daily feed intake (ADF1) than pigs fed 80% of the lysine 
requirement (Table 5.2). Pigs provided inadequate pen space (.025 BW67 kg) had 
lower ADG (P <  .01), ADFI (P <  .01), and gain/feed (P <  .03) than pigs 
provided adequate pen space (.035 BW 67 kg). Average daily gain was decreased to 
a greater extent by inadequate pen space in pigs fed 80% of the lysine requirement 
than in pigs fed 120% o f the lysine requirement (CP x  pen space effect, P < .01). 
Gain/feed was decreased by inadequate pen space in pigs fed 80% of the lysine 
requirement; however, in pigs fed 120% of the lysine requirement inadequate pen 
space increased gain/feed (CP X pen space effect, P <  .08). Chromium 
supplementation did not affect (P >  .10) ADG, ADFI, or gain/feed during the 
grower phase.
During the finisher phase, pigs fed 120% of the lysine requirement liad less 
(P <  .10) ADFI but similar (P >  .10) ADG compared with pigs fed 80% of the 
lysine requirement. Gain/feed was higher (P <  .10) in pigs fed 120% o f the lysine 
requirement than in pigs fed 80% o f the lysine requirement. Average daily gain and
Table 5.2. Effect of dietary chromium, crude protein level, and pen space on growth performance and carcass characteristics of 
growing-finishing pigs"______________






















0 0 400 400 0 0 
Pot space allowance, m2/pigb
400 400
.m s .035 .035 .035 .025 _ .025 __ .025 .025
.685 .750 .678 .728 .594 .715 .598 .696 .019
2.101 2.006 2.077 1.982 1.951 1.898 1.935 1.853 .049
.326 .374 .327 .368 .304 .376 .307 .376 .004
.833 .839 .859 .826 .732 .767 .781 .756 .019
3.472 3.115 3.283 3.367 3.112 2.878 3.147 2.974 .136
.240 .269 .261 .249 .238 .267 .250 .255 .010
.774 .805 .789 .788 .674 .747 .701 .734 .016
2.915 2.689 2.811 2.802 2.617 2.521 2.612 2.536 .080
.265 .299 .280 .283 .258 .297 .268 .289 .007
Carcass characteristics
LMA, cm26* 30.4 35.0 30.0 33.5 31.4 35.7 32.1 35.7 .8
TRF, cme,w 3.1 2.5 2.9 2.5 2.6 2.0 2.7 2.3 .1
PM, %e>f 45.9 49.1 45.8 49.0 47.7 51.6 47.7 50.9 .5
DP. % 74.6 75.2 75.0 74.9 75.3 75.4 75.0 75.5 .5
'Data are means of four replicates of four pigs per replicate; average initial BW =  27.2 kg ; LMA=longissimus muscle area, 
TRF=tenth rib fat thickness, PM=percentage of muscling, DP= dressing percentage.
bWhittemore, 1993. Adequate pen space, m2/pig = .035 BW-*7, kg; Inadequate pen space (crowded), m2/pig =  .025 BW'67, kg. 
*CP effect, P <  .01.
*0? effect. P  <  .03.
*CP effect, P <  .10.
'Pen space effect, P <  .01.
*Pen space effect, P < .03. 
hCP x  Cr effect, P <  .05.
*CP x  Cr effect, P <  .09, 
jCP x  pen space effect, P < .01.
‘‘CP x  pen space effect, P <  .08.
'Cr x  pen space effect, P < .07.
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ADFI were lower (P <  .01) in pigs provided inadequate pen space than in pigs 
provided adequate pen space. Gain/feed was not affected (P >  . 10) by pen space.
In pigs fed 80% of the lysine requirement, Cr supplementation increased ADG and 
gain/feed; however, in pigs fed 120% of the lysine requirement Cr supplementation 
decreased ADG and gain/feed (CP x  Cr effect, P <  .09 and P <  .05, 
respectively).
During the overall combined grower and finisher phases pigs fed 120% of the 
lysine requirement had higher (P <  .01) ADG and gain/feed and lower (P <  . 10) 
ADFI than pigs fed 80% of the lysine requirement. Pigs provided inadequate pen 
space had lower (P <  .01) ADG and ADFI, but similar gain/feed (P > .10), than 
pigs provided adequate pen space. In pigs fed 80% of the lysine requirement, Cr 
supplementation increased gain/feed; however, in pigs fed 120% of the lysine 
requirement Cr supplementation decreased gain/feed (CP x  Cr effect, P <  .05). 
Carcass Traits
Pigs fed 120% of the lysine requirement had greater (P <  .01) LMA and PM 
and less (P < .01) TRF than pigs fed 80% of the lysine requirement (Table 5.2). 
Pigs provided inadequate pen space had greater LMA (P <  ,03) and PM (P <  .01) 
and less TRF (P <  .01) than pigs provided adequate pen space. Chromium 
supplementation increased TRF in pigs provided inadequate pen space; however, Cr 
supplementation decreased TRF in pigs provided adequate pen space (Cr Xpen 
space effect, P <  .07).
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Plasma M rtahnlitre and Hnrmnnea
Prefeeding. In pigs that were fed 120% of the lysine requirement, plasma 
glucose (P <  .11), NEFA (P <  .03), and urea N (P <  .01) were greater, but 
plasma cholesterol was lower (P <  .01) than in pigs fed 80% of the lysine 
requirement (Table S.3). Chromium supplementation decreased plasma NEFA 
concentration of pigs fed 80% of the lysine requirement but increased plasma NEFA 
concentration of pigs fed 120% of the lysine requirement (CP x  Cr, P <  .10). In 
pigs provided inadequate pen space, increasing dietary lysine (120% of requirement) 
increased plasma glucose; however, in pigs given adequate pen space, dietary lysine 
did not affect plasma glucose concentration (CP x pen space effect, P <  . 11). In 
pigs provided inadequate pen space, Cr supplementation decreased plasma insulin of 
pigs fed 80% of the lysine requirement but did not affect plasma insulin of pigs fed 
120% o f the lysine requirement. However, in pigs provided adequate pen space, Cr 
supplementation increased plasma insulin of pigs fed 80% of the lysine requirement 
but decreased plasma insulin of pigs fed 120% o f the lysine requirement (CP X Cr 
x  pen space effect, P <  .08). Plasma GH was not affected (P > . 10) by 
treatment.
Pnstfeeding. In pigs that were fed 120% of the lysine requirement, plasma 
glucose (P <  .11), NEFA (P <  .11), cholesterol (P <  .01), and GH (P < .01) 
were lower, but plasma urea N and insulin were higher (P <  .01) than in pigs fed 
80% of the lysine requirement (Table 5.3). In pigs provided adequate pen space, Cr
Table 5.3. Effect of dietary chromium, crude protein level, and pot space on plasma glucose, NEFA, insulin, and growth 
hormone concentrations of growing-finishing pigs1_________________________________________________________
Percentage of lysine requirement
80 120 80 120 80 
Cr. ue/kp diet
120 80 120
0 0 400 400 0
Pen soace allowance. m2/meb
0 400 400
Pooled
Criterion .035 .035 .035 .035 .025 .025 .025 .025 SEM
Glucose, mmol/L 
Unfed* 4.5 4.5 4.6 4.5 4.3 4.6 4.3 4.5 .1
Fed* 5.8 5.5 6.4 5.8 6.0 5.9 6.0 5.7 .3
NEFA, mEq/L
Unfed44 .64 .73 .57 .80 .74 .72 .59 .76 .07
Fed* .i6 .12 .14 .13 .16 .14 .17 .13 .02
Insulin, pU/mL 
Unfed" 6.0 4.4 4.1 4.5 3.8 5.6 7.0 5.1 1.1
Fed*4 19.1 28.0 17.5 38.4 15.4 41.8 21.3 32.1 5.7
Growth hormone, ng/mL 
Unfed 9.5 7.7 6.6 4.7 7.4 4.4 6.4 6.8 1.6
Fed* 11.4 9.7 11.9 8.5 13.8 7.7 12.2 8.9 1.8
Urea nitrogen, mmol/L 
Unfed* 5.5 7.9 5.5 7.9 5.2 8.3 4.9 8.4 .5
Fed* 5.8 9.5 5.6 8.0 6.0 8.5 5.7 8.5 .5
(table con’d)
Cholesterol, mmol/L
Unfed6 2.6 2.2 2.5 2.1 2.6 2.2 2.7 2.2 .1
Fed6_____________ 2.7 2.3 2.5 2 3   2.6 2.3 2.7 2.4 .1
'Data are means of four replicates with four pigs per replicate; average initial BW = 27.2 kg; Unfed = 20 h without access to 
feed; Fed -  2 h postfeeding.
bWhittemore, 1993. Adequate pen space, m2/pig =  .035 BW 67 kg; Inadequate pen space (crowded), m2/pig =  .025 BW 67 kg. 
6CP effect, P <  .01.
"CP effect, P <  .03.
'CP effect, P < .11. 
fCP X Cr effect, P < .10.
*CP x  pen space effect, P <  .11. 
bCP x  Cr x  pen space effect, P <  .08.
*CP x  Cr x  pen space effect, P <  .10.
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supplementation decreased plasma insulin of pigs fed 80% of the lysine requirement 
but did not change plasma insulin o f pigs fed 120% of the lysine requirement. 
However, in pigs provided adequate pen space, Cr supplementation increased 
plasma insulin of pigs fed 80% of the lysine requirement but decreased plasma 
insulin of pigs fed 120% of the lysine requirement (CP x  Cr x  pen space effect,
P <  .08).
Discussion
The literature shows varied growth performance responses to Cr 
supplementation of pig diets. Page et al. (1993b) reported either decreased growth 
performance or no effect of Cr supplementation in separate experiments.
Lindemann et al. (1995) reported that 250 and 500 ppb Cr as CrPic tended to reduce 
ADFI without affecting ADG, resulting in an increase in gain/feed ratio. However, 
Evock-Clover et al. (1993) reported no effect of CrPic on ADG, ADFI, or 
gain/feed. Mooney and Cromwell (1995) reported that CrPic increased ADG but 
did not affect ADFI or gain/feed. The current data are consistent with those of 
lindemann (1993) whereby Cr supplementation of diets that are deficient in lysine 
(or at least marginally so) improves feed efficiency (and ADG, finisher phase only). 
The mechanism responsible for this effect is not known; however, the involvement 
of Cr in RNA and DNA synthesis (Okada et al., 1984) may be responsible or an 
increase in amino acid uptake (Hegsted et al., 1995).
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The effects o f crowding on the growth performance of pigs are known 
(Komegay and Notter, 1984; NCR-89, 1986). Crowding previously has been 
reported to reduce growth performance of pigs primarily through its effect of 
reducing feed intake (Komegay et al., 1993; Moser et al., 1985; NCR-89, 1986). 
However, there has been some discussion as to whether increasing the nutrient 
density o f pigs diets could overcome the effects of some stressor (e.g., crowding) 
(Baker, 1995). Our data indicate that increasing the CP content o f the diet will 
improve growth performance of pigs that have been subjected to crowding.
Carcass Traits
As expected, the pigs fed lysine (and CP) adequate diets had greater LMA and 
less TRF than pigs fed inadequate lysine. The presence of adequate or perhaps 
excess dietary amino acids coupled with the increased feed efficiency of pigs fed 
120% of the lysine requirement were probably responsible for this dramatic effect. 
However, the improved carcass traits o f pigs that were given inadequate pen space 
was not necessarily expected. The response was probably due not only to decreased 
ADFI of crowded pigs but also a generally slower growth rate. Another possible 
cause of the reduction in TRF may have been a reduction in glucose utilization by 
the adipose tissue with subsequent reduction in lipogenesis as reported by 
Rosebrough and Steele (1986). However, feed efficiency of crowded pigs was 
decreased or not affected by crowding. One would expect that an increase in feed 
efficiency would be coupled with increased carcass lean. Zimmerman (1995)
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reported similar increases in muscling and decreases in fat due to reducing pen space 
in pigs fed to 136 kg.
We had originally hypothesized that stressed (i.e., crowded) pigs may respond 
to Cr supplementation more readily than unstressed (i.e., uncrowded). However, no 
main effects of Cr supplementation were observed for carcass traits. In fact, Cr 
supplementation of crowded pigs tended to make the carcasses o f those pigs fatter 
(i.e., increased TRF). It may be that some other form of stress is necessary or that 
the pigs adapted to the crowding situation and thus were not "stressed”. Another 
possibility is that the linear carcass measurements were not sensitive enough to 
detect differences in carcass composition. Boleman et al. (1995) and Mooney and 
Cromwell (1995) have reported that CrPic supplementation of pig diets resulted in 
increased carcass lean and decreased carcass fat without measurable differences in 
linear carcass measurements. In addition, the rate o f lean accretion was increased 
and the rate o f fat accretion was decreased (Boleman et al., 1995; Mooney and 
Cromwell, 1995).
Lindemann et al. (1993) reported that the level of dietary CP may affect the 
response obtained from Cr supplementation; pigs fed marginal levels of CP (lysine) 
had increased muscling and decreased fat in response to Cr supplementation. 
However, Harris et al. (1995) reported no effect of dietary CrPic on growth 
performance or carcass characteristics of pigs fed adequate and low CP diets. Some 
investigators have hypothesized that pigs that have increased potential for lean gain
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may not be as responsive to Cr supplementation as pigs with less potential for lean 
gain (Roger Campbell, Prince Nutrition Conference, 1993). The pigs in the current 
experiment had an average PM of 48.5% even with the low lysine treatments (pigs 
with adequate lysine PM — 50.2%). Previous studies that have demonstrated 
positive responses to Cr supplementation have typically used pigs with PM in (he 
low to mid 40%’s (Page et al., 1993a,b). The specific conditions necessary to elicit 
improved carcass characteristics or carcass composition of pigs fed supplemental Cr 
are not known. However, as we previously hypothesized (see Chapter 1 and 2), the 
level o f stress, genotype, or Cr status may affect the response to Cr 
supplementation.
Both insulin and glucose have been reported to reduce plasma NEFA 
concentrations (Dole, 1956). Therefore, the increased plasma NEFA after 20 h 
without access to feed in pigs fed 120% o f the lysine requirement compared with 
pigs fed 80% o f the lysine requirement is an enigma. These pigs tended to have 
higher plasma glucose but lower plasma insulin concentrations than pigs fed 80% of 
the lysine requirement. One would expect that die lower carcass lipid stores (lower 
TRIO would have resulted in less adipose stores for NEFA mobilization. In fact, 
this seems to be the case in the 2 h postfeeding samples. Pigs tied 120% of the 
lysine requirement had higher plasma insulin and lower plasma NEFA 
concentrations. Atinmo et al. (1978) reported that protein-malnourished pigs failed
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to respond to arginine-induced insulin release. Furthermore, protein-malnourished 
pigs had higher NEFA levels than control pigs. These findings support the current 
data, in which pigs fed 80% of the lysine requirement had lower plasma insulin and 
higher plasma NEFA concentrations 2 h postfeeding than pigs fed 120% of the 
lysine requirement. In addition, growth hormone is associated with increased 
lipolysis (Keller and Miles, 1991) and may be involved in the higher plasma NEFA 
levels o f pigs fed 80% of the lysine requirement compared with pigs fed 120% of 
the lysine requirement. Plasma urea N was higher in pigs fed diets containing 
adequate (probably excess) amino acids. These effects have been reported 
previously (Ward and Southern, 1993).
Lindemann et al. (1995) reported that dietary Cr supplementation diminished 
the insulin response to feeding in gestating gilts. Evock-Clover et al. (1993) also 
reported that dietary Cr tended to “normalize" glucose and insulin concentrations in 
pigs injected with ppST. The changes in plasma insulin may depend on both the 
nutritional and environmental status o f the pig, as well as other factors. For 
example, dietary Cr appeared to accentuate the protein-induced increase in plasma 
insulin o f uncrowded pigs. However, dietary Cr supplementation somewhat 
modulated the protein-induced increase in plasma insulin of crowded pigs. Thus the 
ability of a  pig to respond to supplemental Cr may depend on the overall health and 
nutritional status of the pig.
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Amoikon et al. (1995) reported that dietary Cr supplementation decreased 
plasma NEFA level o f growing pigs. In the present investigation, the metabolic 
response to dietary Cr supplementation again appeared to depend on the nutritional 
status of the pig. Dietary Cr supplementation was effective in reducing plasma 
NEFA of pigs fed inadequate lysine, but dietary Cr increased plasma NEFA levels 
of pigs fed adequate lysine. The differences in nutritional or environmental status o f 
pigs may partially account for the varied responses in the literature.
Implications
The assertion that dietary chromium may alleviate “stress” in animals or that 
“stressed” animals may respond in a positive manner to chromium supplementation is 
not apparent in pigs in which restricted pen size is the stressor. However, under 
conditions in which pigs are fed diets which arc inadequate or marginally adequate 
in amino acids (or protein), supplemental dietary chromium may result in improved 
growth performance. Thus, the economic benefits of supplementing pig diets with 
chromium may depend on the production environment and availability o f adequate 
dietary protein as well as other factors.
CHAPTER VI
EFFECT OF DIETARY CHROMIUM TRIPICOLINATE ON GROWTH
PERFORMANCE, BODY COMPOSITION, PLASMA METABOLITES 
AND HORMONES, AND GLUCOSE TOLERANCE AND INSULIN 
SENSITIVITY IN BROILERS
Introduction
Chromium is known to influence protein, lipid, and carbohydrate metabolism, 
and it has been'shown to promote growth in turkey poults (Steele and Rosebrough, 
1979, 1981; Rosebrough and Steele, 1981) and to increase N utilization in lambs 
(Britton et al., 1968). Recently, Cr supplementation of swine diets was reported to 
increase carcass muscling and decrease tenth rib fat thickness (Lindemann et a l., 
1993, 199S; Page et al., 1993a,b). Boleman et al. (1995) and Mooney and 
Cromwell (1995) also have reported that dietary Cr increased the rate o f lean 
deposition and decreased the rate of fat deposition in pigs.
Consistent reduction of the fat content of broiler carcasses has eluded the 
poultry industry. Chromium is capable of facilitating the action of insulin (Mertz, 
1969); therefore, it may be efficacious in modulating insulin and glucose 
metabolism. Lower plasma glucose and higher plasma insulin has been associated 
with increased body fat in growing broilers (Touchbum et a l., 1981). Because of 
the association of Cr with nutrient utilization and improvements in body composition 
(increased muscling and decreased fat), it may be possible to supplement broiler 
diets with Cr and achieve improvements (increased lean and decreased fat) in carcass
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composition. Therefore, these experiments were conducted to determine the effect 
of dietary Cr as CrPic on growth performance, carcass composition, and glucose 
clearance rate in broilers.
M aterials and Methods 
Three experiments were conducted to determine the effects of dietary Cr as Cr 
tripicolinate (CrPic) on growth performance and body composition of broilers. An 
additional experiment was conducted to determine the effect of dietary CrPic on 
glucose clearance rate and insulin sensitivity of broilers. Unless otherwise indicated, 
all birds were housed in heated starter batteries during the first 2 weeks (wk) of each 
experiment and moved to grower batteries during the ensuing experimental periods. 
Battery pens were housed in an environmentally controlled building. Starter 
batteries, as well as the room in which both starter and grower batteries were 
housed, contained continuous fluorescent lighting.
Experim ent 1
An experiment was conducted using unsexed Arbor Acres x  Arbor Acres 
broiler chicks (Sanderson Farms, Laurel, MS) from 5 to 19 days of age. From 
hatching to 4 days posthatching, all chicks were fed a com-soybean meal diet (Table 
6.1). After they were deprived of feed overnight, chicks were weighed and 
randomly assigned to treatments on the basis of body weight (BW; average initial 
BW =  64.2 g). Each treatment consisted of four replicates of five chicks each. A 
control treatment (four pens of five chicks each) without Cr supplementation was
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Table 6.1. Composition o f the basal diet, as-fed basis (Exp. 1)
I n g r e d i e n t _____________________________________________________ %
Com 47.14
Soybean meal, 44% CP 42.S0
Com oil 5.00
Defluorinaled rock phosphate 2.1.0
Alfalfa leaf meal 2.00













Methionine +  cystine .87
Lysine 1.28
Metabolizable energy, kcal/lcg 3,038
'Roche Chemical Division, Nutley, NJ 07110. Provided the following per kilogram of 
diet: vitamin A (retinyl acetate), 6,614 IU; cholecalciferol, 1,653 IU; dl-a-tocopheryl 
acetate, 7 IU; menadione, 1.5 mg; thiamine, 1.1 mg; riboflavin, 6.6 mg; niacin, 33.1 mg; 
d-pantothenic acid, 11.0 mg; folic add, .7 mg; pyridoxine, 1.1 ing; d-biotin, .055 mg; 
vitamin Bw, .011 mg; choline (as chloride), 551 mg.
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included. The basal diet was supplemented with 0, 200, or 400 Atg Cr/kg diet as 
CrPic (12% Cr). Chicks were allowed ad lihitum access to feed and water.
Total fecal collections were taken from day 10 to 14 of the experiment at 24 h 
intervals. The feces were pooled by replicate, lyophilized, and ground. Kjeldahl 
nitrogen (N) analysis was conducted on the feed and fecal samples. At the 
termination of the experiment (day 14), individual chicks were weighed and pen 
feed consumption was determined. All chicks were killed via cervical dislocation. 
Three chicks per replicate were randomly selected and nmscle samples o f the breast 
and leg were collected. The other two chicks per replicate were placed in plastic 
bags and frozen for later whole-body compositional analyses. Moisture percentage 
of the muscle samples was determined after lyophilizing. Ether extract was 
conducted by Soxhlet extraction (ethanol and diethyl ether, 20 h each). Kjeldahl N 
analysis of the meat samples also was conducted. For whole-body composition, 
chicks were defrosted, weighed, placed in a stainless-steel blender container, and 
autoclaved for 90 min (121 °C and 1.27 kg/cm2). Samples were cooled for 15 min, 
water was added (10% of the chick weight), and the sample was blended until 
smooth. Samples o f the slurry were dried in a  forced-air oven (100°C for 16 h) for 
dry matter (DM) determination. After drying the samples were placed in a muffle 
furnace (600°C for 8 h) for determination of ash. An additional sample was 
lyophilized, ground, and analyzed for Kjeldahl N. Fat analysts of the slurry was 
conducted by rapid analysis methodology using a CEM Model AVC 80 analyzer
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(AOAC, 1990). All whole-body analyses were conducted in duplicate and were 
corrected for moisture content (i.e., expressed on a dry matter basis).
Experim ent 2
Male Ross x  Peterson broilers (Sanderson Farms, Laurel, MS) were allowed 
a 4-d adaptation period as in Exp. 1. The chicks (average initial BW — 81 g) were 
then randomly assigned to four dietary treatments: 1) com-soybean meal basal 
(Table 6.2), 2-4) the basal diet plus 400, 1,600, or 16,000 g Cr as CrPic/kg diet. 
Each treatment was replicated three times with five chicks per replicate pen. A 
control treatment (three pens of five chicks each) without Cr supplementation was 
included. The chicks were weighed weekly and pen feed intake was determined 
weekly. The chicks were bled (approximately 3 mL) via wing vein puncture 
following 12 h without access to feed (fasted) and again 2 h postfeeding on day 25 
of the experiment. The blood was placed into tubes (Monoject®, Sherwood 
Medical, St. Louis, MO) containing 8 mg potassium oxalate and 10 mg sodium 
fluoride and immediately placed on ice. The blood was centrifuged (1,600 x  g for 
20 min at 4°C) and the plasma was collected and frozen for later hormone and 
metabolite analyses. The chicks were killed via CQj inhalation on day 28 of the 
experiment. The digestive tract of each chick was removed and cleaned of contents. 
In addition liver, heart, and ventriculus weights were recorded. The digestive tract 
and organs were then placed into plastic “ziplock" bags with the carcass and frozen 
for subsequent proximate analyses methods as in Exp. I.
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Table 6.2. Composition of the basal diet, as-fed basis (Exp. 2)
Ingredient %
Soybean meal, 44% CP 46.18
Com 41.99
Com oil 6.00
Alfalfa leaf meal 2.00
Dicalcium phosphate 1.53












Methionine +  cystine .93
Lysine 1.36
Metabolizable energy, kcal/kg 3,039
'Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU; 
cholecalciferol (deactivated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU; 
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-pantothenic acid (d-calcium pantothenate), 8.1 mg; folic add, .33 
mg; d-biotin, .055 mg; vitamin B13, .011 mg; choline (as chloride), 382 mg; manganese 
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg; 
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; ethoxyquin, 125 
mg.
'’Provided .1 mg Se per kilogram of diet as NajSeOj.
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E xperim ent
Male and female (two replicates of five chicks of each sex; average initial 
BW =  79 g) were randomly assigned to three dietary treatments. The chicks were 
fed one of the following three diets: 1) a com-soybean basal diet (Table 6.3), 2) the 
basal diet plus 400 pg  Cr as CrPic/kg diet, or 3) the basal diet plus 1,600 p g Cr as 
CrPic/kg diet. The diets were reduced in crude protein (CP) content as 
recommended by the NRC (1994) at wk 3 and wk 6 of the experiment (Table 4.5). 
The cliicks were weighed weekly and feed intake was determined weekly.
The chicks were bled (approximately 5 mL) via wing vein puncture 
following 12 h without access to feed (fasted) and again 2 h postfeeding on day 45 
o f the experiment. The blood was placed into tubes (Monoject®) containing 14 mg 
potassium oxalate and 17.5 mg sodium fluoride and immediately placed on ice. The 
blood was centrifuged (1,600 x  g for 20 min at 4°C) and the plasma was collected 
and finozen for later hormone and metabolite analyses. The birds were killed via 
CQt inhalation on day 49 of the experiment. The digestive tract of each chick was 
removed and cleaned of contents. Liver, heart, spleen, proventriculus, small and 
large intestine, and ventriculus weights were recorded. Both breasts and the right 
leg and thigh o f each bird were dissected of lean tissue. The lean tissue weight and 
the abdominal fat pad weight o f each bird were recorded. The digestive tract, 
organs, and dissected tissues were then placed into plastic “ziplock* bags with the 
carcass and frozen for subsequent proximate analyses.
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T^ble6;3;iCom^sitiOT^sA e^^d^eteiias^^!̂ M is_^^=3^
Wlf o f P.yppriment
Ingredient_____________________ (K3_____________ 3^>_______________ 6-7
Soybean meal, 4496 CP 46.18 54.95 61.04
Com 41.99 33.40 27.64
Com oil 6.00 6.00 6.00
Alfalfa leaf meal 2.00 2.00 2.00
Dicalcium phosphate 1.53 1.19 1.00
Oyster shell flour 1.35 1.51 1.37
Vitamin-mineral premix1 .25 .25 .25
Salt .40 .40 .40
DL-Methionine .20 .20 .20
Selenium premixb .10 .10 .10
Total 100.00 100.00 100.00
Nutrient
Calculated
Crude protein 23.00 20.00 18.00
Calcium 1.00 .90 .80
Total phosphorus .69 .63 .56
Available phosphorus .45 .40 .35
Methionine +  Cystine .93 .85 .79
Lysine 1.36 1.13 .97
Metabolizable energy, kcal/kg 3,039 3,141 3,217
•Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU; 
cholecalciferol (d-activated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU; 
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-pantothenic acid (d-calcium pantothenate), 8.1 mg; folic acid, .33 
mg; d-biotin, .055 mg; vitamin B,a, .011 mg; choline (as chloride), 382 mg; manganese 
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg; 
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; ethoxyquin, 125 
mg.
'’Provided . 1 mg Se per kilogram of diet as Na2Se03.
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Proxim ate Analyses
In Exp. 2 and 3, three birds per replicate were selected at random for carcass 
compositional analyses. The carcass, digestive tract, and tissues of each bird were 
thawed, separated, and weighed. In Exp. 2 the digestive tract plus organs (Gut) and 
in Exp. 3 the leg plus thigh meat (Dark), and breast meat (W hite), and Gut were 
ground individually in a  Hobart (Model No. A-200) grinder equipped with a .64 cm 
die and then further ground in a food processor. Samples of the Gut, Dark, and 
White were placed into 7.6-cm x  12.7-cm plastic "ziplock" bags. The remainder of 
the carcass was placed into a stainless-steel container, enclosed with a plastic 
cooking bag (Reynolds Metal Co., Richmond, VA), and autoclaved for 120 min 
(121°C and 1.27 kg/cm2). The carcass was immediately blended until smooth and a 
sample of the resultant slurry was placed into a 7.6-cm x  12.7-cm plastic "ziplock” 
bag. Ten percent of the Gut, Dark, and White tissues from each bird within a 
replicate were included in the pooled sample. One percent o f the weight of each 
carcass within a  replicate was used for pooling. Pat and moisture analyses of each 
of the pooled samples (Gut, Dark, White, and carcass) were conducted by rapid 
analysis methodology using a CEM Model AVC 80 analyzer (AOAC, 1990). 
Duplicate samples of the slurry were dried in a forced-air oven (100° C for 12 h) for 
DM determination. After drying, the samples were placed in a  muffle furnace 
(5S0°C for 12 h) for determination of ash. An additional sample was lyophilized, 
ground, and analyzed for Kjeldahl N.
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Experiment A
An experiment was conducted to determine the effect of dietary Cr as CrPic 
on glucose tolerance and insulin sensitivity in mature broilers. Twenty-eight-day-old 
unsexed Arbor Acres x  Arbor Acres broilers (Sanderson Farms, Laurel, MS) were 
used. From hatching to 28 days posthatching, all broilers were fed a com-soybean 
meal diet (Table 6.1). After they were deprived of feed overnight, the broilers were 
weighed and randomly assigned to treatments on the basis o f BW (average initial 
BW = 976 g). Chicks were provided continuous fluorescent lighting and caged in 
starter batteries with raised wire floors. The battery heaters were not used and every 
other battery level was used to allow adequate space for the broilers. Each treatment 
consisted o f four replicate pens of five chicks each. The basal diet was 
supplemented with 0 (a control treatment) or 200 ^g Cr/kg diet as CrPic. Chicks 
were allowed ad lihitnm access to feed and water. The diets were changed at 6 wk 
of age as recommended (Table 6.4; NRC, 1994).
Growth performance [average daily gain (ADG), average daily feed intake 
(ADFI), and gain/feed] was measured from 28 to 58 days of age. On day 58, two 
broilers per replicate were randomly selected to remain on treatment diets; the other 
three broilers were killed via C 02 inhalation. The remaining broilers were fed the 
treatment diets until approximately 11 wk of age. After being without feed 
overnight, the broilers were fitted with brachial vein catheters. This was 
accomplished by inserting a 16-gauge needle into the brachial vein and passing
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Table 6.4. Composition of the basal diets, as-fed basis (Exp. 4)
________Wk of Experiment
Ingredient___________________________3^6______________________ 6-11
Soybean meal, 44% CP 57.04 64.80
Com 33.97 27.95
Com oil 6.04 4.62
Defluorinated nock phosphate 1.40 1.17
Oyster shell flour .90 .88
Vitamin-mineral p remix* .25 .25
Salt .24 .24





Crude protein 20.00 18.00
Calcium .90 .80
Total phosphorus .63 .57
Available phosphorus .40 .35
Methionine +  Cystine .72 .65
Lysine 1.13 .97
Metabolizable enerfiVT kcal/kg 3.200 3,200
"Provided the following per kilogram of diet: vitamin A (retinyl acetate), 11,000 IU; 
cholecalciferol (d-activated animal sterol), 1,650 IU; dl-a-tocopheryl acetate, 8 IU; 
menadione (menadione sodium bisulfite), .72 mg; thiamine (mononitrate), 1 mg; riboflavin,
4.4 mg; niacin, 33 mg; d-paiitothenic acid (d-calcium pantothenate), 8.1 mg; folic acid, .33 
mg; d-biotin, .055 mg; vitamin B12l .011 mg; choline (as chloride), 382 mg; manganese 
(oxide), 60 mg; zinc (sulfate), 44 mg; iron (ferrous sulfate), 20 mg; copper (oxide), 2 mg; 
iodine (ethylenediamine dihydriodide), 1.2 mg; cobalt (carbonate), .2 mg; etlioxyquin, 125 
mg.
'’Provided . 1 mg Se per kilogram of diet as Na2Se03.
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catheter tubing (i.d., .58 mm; o .d ., .965 mm; Intramedic®, Becton Dickinson &
C o., Parsippany, NJ) through the needle. The needle was then removed and the 
tubing remained in the vein. The tubing was glued with "super glue” to the skin 
under the wing, passed behind the wing, and taped to the back of the bird. Birds 
were held in individual pens during blood sampling.
After at least 1 h rest, the broilers were given a bolus dose of .88 g glucose/kg 
BW intravenously (TVGTT) as a 50% solution in .9% NaCl. Blood samples were 
collected at -10, 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, 120, 150, 180 min relative to 
glucose infusion. The blood was placed into tubes containing 10 mg sodium 
fluoride and 8 mg potassium oxalate and immediately placed in an ice bath. The 
blood samples were centrifuged (1,600 x  g for 20 min at 4°C) and the plasma wits 
collected and frozen for later hormone and metabolite analyses. At least 2 h after 
the last sample was collected in the IVGTT, an intravenous insulin challenge test 
(TVTCT) was conducted. The broilers were administered i.v. 1.5 U bovine insulin 
(Sigma Cat.# 1-5500, Lot# 112H0353, Sigma Chemical Co., St. Louis, MO)/kg BW 
as a bolus dose. The insulin was administered as a solution containing 13.5 U/niL 
in .9% NaCl containing .2% bovine serum albumin (Fraction V Powder, Cat.# 810- 
1018, Lot# A090767, Grand Isle Biological Co., Grand Isle, NY). Blood samples 
were collected in the same manner as the IVGTT and at the same time points 
relative to i.v. infusion of insulin.
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Glucose clearance rate (k, %/rain) and half-life (min) were calculated between 
IS to 45 min and 0 to 60 min for the IVGTT and IVICT, respectively, as a 
modification of the procedure outlined by Kaneko (1989). Insulin clearance rate (k, 
%/min) and half-life (min) during the IVGTT were calculated from 15 to 30 min.
Approximately 2 d after the IVGTT and IVICT, a least sampling minimal 
model glucose tolerance test (LSMM) was conducted (Ader et al., 1985; Bergman, 
1989). This procedure amounts to a combination IVGTT and IVICT. The basis o f 
such a procedure is to separate, via computer analysis, the insulin and glucose 
effects on glucose clearance from the plasma. The techniques have been used 
successfully in mammals (Ader et a l., 1985; Yang et a l., 1987; Bergman, 1989).
The methodology is similar to the IVGTT and IVICT previously conducted. The 
broilers were administered i.v. .528 g glucose/kg BW at time 0. Blood samples 
were collected as described previously except at -1 ,2 , 4, 8, 19,22, 30, 40, 50, 70, 
90, and 180 min relative to glucose administration. In addition, at 20 min 
postinfusion of glucose, .75 IU bovine insulin/kg BW was administered i.v.
Chemical Analyses
Plasma cholesterol (Sigma, 1989), glucose (Sigma, 1990), and NEFA (TVGTT 
-10 min samples only, NEFA-C Kit, ACS-ACOD Method; Wako Chemicals USA, 
Inc., Richmond, VA) were analyzed using spectrophotometric procedures outlined 
in commercially-available kits.
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Insulin was measured in plasma samples with a homologous radioimmunoassay 
previously validated for chicken tissues (McMurtiy et al., 1983). Antiserum against 
chicken insulin (supplied by J.P . McMurtiy, USDA, Beltsville, MD) was diluted 
1:20,000 in normal guinea pig serum (1:400), and 200 #*L of this solution was used 
per tube. Highly purified chicken insulin (obtained from D.J. Bolt, USDA, 
Beltsville, MD) was radioiodinated via the chloramine-T method (Greenwood et al., 
1963), and was used at approximately 40,000 cpm/tube. An aliquot of the highly 
purified hormone was diluted to 10 ng/mL and used as the reference standard. For 
assay, samples (between 100 and 200 /iL) and standards were mixed with the first 
antibody and were incubated *24 h. All incubations were at S°C. After addition of 
labeled hormone, the tubes were vortexed and then incubated *24 h. Diluted (1: IS) 
antiserum generated in a sheep against guinea pig gamma-globulin was added, and 
the tubes were vortexed and incubated *48 h. The precipitated insulin-antibody 
complexes were harvested by centrifugation after addition of 2 mL of .01 M 
phosphate-buffered .155 M saline. Serial dilution o f chicken plasma produced an 
inhibition curve in the assay parallel to the reference standard, and recovery of 
purified chicken insulin added to a low-insulin plasma pool was 115%. Sensitivity 
of the assay was .02 ng; intra- and interassay coefficients o f variation averaged 8 
and 10%, respectively. Due to the crossreactivity o f bovine insulin with the chicken 
insulin assay, insulin analysis was not conducted on the IVICT or LSMM samples.
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Plasma immunoreactive glucagon was assayed as outlined by Gaskins et al. 
(1991). Rabbit anti-porcine glucagon antibody (Unger 04A, Pool 1, Lot #22; R.H. 
Unger, Southwestern Medical Center, The University of Texas, Dallas, TX) specific 
for small molecular weight (3,500 mol. wt.) glucagon was used at a final dilution of 
1:112,500. Purified porcine-bovine glucagon (Product No. G-2450; Sigma 
Chemical Co.) was the standard. Porcine 125I-glucagon (Product No. 07-152126; 
ICN Biomedicals, Inc.) was the radioligand, and goat anti-rabbit immunoglobulin G 
prepared in the laboratory o f Donald L. Thompson, Jr. (Louisiana State University 
Agricultural Center, Baton Rouge, LA) was used at a 1:12 dilution as the 
precipitating antibody. The intraassay CV as determined by pooled turkey plasma 
samples was 5.8%.
Statistical A n a ly se
The growth performance, organ and tissue weight, metabolite and hormone, 
and carcass composition data were analyzed as completely random designs using the 
pen as the experimental unit. In Exp. 3, the data were analyzed as a 3 x  2 factorial 
arrangement o f treatments in a completely random design. The two factors were 
three levels o f Cr and two sexes. In Exp. 4, the glucose and insulin clearance data 
were analyzed as a  completely random design using the individual bird as the 
experimental unit. The LSMM data was analyzed as a split-plot in time with 
replicate within treatment as the error term in the model to test for treatment effects.
Results
Experiment 1
Supplemental dietary Cr did not affect (P >  .10) ADG, ADFI, gain: feed 
ratio, or N balance fTable 6.5). Supplemental Cr did not affect (P >  . 10) the 
percentage of CP, moisture, or ether extract in breast and leg muscle samples. In 
addition, Cr supplementation did not affect (P >  .10) whole-body CP, fat, or ash 
percentage. However, dietary Cr supplementation decreased percentage of DM 
(quadratic effect, P <  .09). In addition, 200 Mg Cr/kg diet tended to decrease 
(P <  . 13) fat percentage compared with the control diet.
E xperim ent 2
Dietary Cr supplementation did not affect (P >  .10) ADG, ADFI, or 
gain/feed (Table 6.6). Chromium supplementation did not affect (P >  .10) liver, 
heart, o r abdominal fat pad weights; however, ventriculus weight was increased (Cr 
cubic effect, P <  .07) in broilers fed supplemental Cr. Dietary Cr supplementation 
increased carcass ash percentage (Cr quadratic effect, P <  .06); however, carcass 
and Gut moisture, fat, CP, and Gut ash percentage were not affected (P >  .10) by 
dietary Cr supplementation. Dietary Cr supplementation did not affect (P >  .10) 
plasma NEFA, cholesterol, glucose, insulin, or glucagon concentrations in the fed 
or fasted state.
96
Table 6.5. Effect of dietary chromium on growth performance, N balance, and breast and
legjnusd^n^wh^^bod^com^sition^ t̂oJQ^^^ l̂̂ l̂SJ^^EiJil
Dietary Cr, jug/kg
------------------------------------------------------------- Pooled
Item__________________ 0_____________200____________ 400_________ SEM
Growth performance 
ADG, g/chick 26.8 26.8 26.6 .5
ADFI, g/chick 36.7 36.6 36.7 .5
Gain:feed .731 .732 .725 .009





























CP, % of DM 
Fat, % o f DM 

















“Growth performance data are means of four replicates o f Eve broilers each. Breast and leg 
composition data are means of four replicates of three chicks each and whole-body 
composition data are means of four replicates of two chicks each. 
bCr quadratic effect, P <  .09.
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Table 6.6. Effect of dietary chromium on growth performance, organ weights, body
Dietary Cr, //g/kg
Pooled
SEMItem 0 400 1.600 16.000
Growth performance
ADG, g/chick 49.3 49.2 49.9 49.1 .8
ADFI, g/chick 80.1 81.5 82.0 80.5 1.2
Gain:feed .615 .604 .608 .610 .010
Organ weights, % BW
Liver 2.82 2.89 3.03 2.89 .11
Heart .64 .62 .66 .63 .03
Ventriculusb 1.57 1.78 1.84 1.83 .05
Abdominal fat pad .53 .56 .55 .59 .04
Body Composition 
Carcass
Moisture, % 68.8 68.9 69.7 68.3 .7
Fat, % 8.3 8.5 7.9 8.9 .4
CP, % DM 61.7 63.2 64.0 63.4 1.5
Ash, % DM* 9.2 9.4 9.7 8.9 .2
Gut
Moisture, % 71.8 72.8 73.9 72.5 1.0
Fat, % 6.2 4.7 5.0 5.9 1.0
CP, % DM 68.4 68.1 65.4 64.5 3.3
Ash, % DM 5.0 5.0 4.9 4.7 .2
Metabolites & hormones 
Fed
NEFA, mEq/L .393 .397 .378 .389 .012
Cholesterol, mmol/L 2.8 2.9 2.7 2.6 .1
Glucose, mmol/L 11.32 11.79 11.59 11.96 .20
Insulin, ng/mL 1.35 1.13 1.26 1.07 .19




NEFA, mEq/L .620 .588 .581 .547
Cholesterol, mmol/L 2.6 2.7 2.4 2.6
Glucose, mmol/L 9.91 10.21 9.98 10.35
Insulin, ng/mL .90 .96 .79 .82
Glucagon, pg/mL 736.7 794.5 668.9 810.1 94.1
•Data are means of three replicates o f five broilers each; avg. initial wt. =  81 g. 
bCr cubic effect, P <  .07.
*Cr linear effect, P <  .04, quadratic effect, P <  .06.
99
Experiment 3
During the first three wk, dietary Cr supplementation did not affect (P >  .10) 
ADG; however, gain/feed was increased (Cr quadratic effect, P <  .06) in birds fed 
supplemental Cr (Table 6.7). Males grewer faster and ate more feed than females 
(Sex effect, P <  .OS). During wk 0 to 3, males ate the most feed when fed the diet 
containing 400 ppb Cr; however, females ale the least feed when fed the diet 
containing 400 ppb Cr (Sex X Cr quadratic effect, P <  .06). During wk three to 
six, neither dietary Cr supplementation nor sex affected (P >  .10) ADG, ADFI, or 
gain/feed. During the last wk of tlie experiment, ADG and gain/feed were higher in 
males than in females (Sex effect, P <  .05). Dietary Cr supplementation increased 
ADG and gain/feed (Cr linear effect, P <  .04); however, ADFI was not affected 
(P >  .10) by dietary Cr supplementation. Males had the highest ADG when fed the 
diet containing 400 ppb Cr; however, females had the highest ADG when fed the 
diet containing 1,600 ppb Cr (Sex x  Cr quadratic effect, P <  .06).
Dietary Cr supplementation did not affect (P >  .10) liver, heart, ventriculus, 
pancreas, spleen, or small intestine weights (Table 6.8). Ventriculus weight as a 
percentage of BW was greater in males than in females (Sex effect, P <  .07).
Proventriculus weight was the lowest in males when fed 400 ppb Cr; however, 
females had the highest proventriculus weight when fed 400 ppb Cr (Sex x Cr 
quadratic effect, P <  .05). Large intestine weight was greatest in males fed the diet
Table 6.7. Effect of dietary chromium on growth performance of 5 to 54-<lay-old broilers (Exp. 3)*
Male Female
Dietary Cr. u s fk z  Pooled
Item_____________________0_________ 400_______ 1,600________ 0__________ 400________ 1,600 SEM
Growth performance 
0-3 wk
ADG, g* 42.2 43.8 42.5 39.7 37.9 39.9 .9
ADFI, gW 66.0 66.2 64.3 62.9 58.7 60.1 1.3
Gainrfeed6*4 .639 .662 .660 .631 .646 .663 .008
3-6 wk
ADG, g 54.4 62.2 64.5 56.9 53.3 52.6 5.9
ADFI, g 128.4 138.7 140.0 128.2 126.3 131.6 9.5
Gaimfeed .419 .449 .461 .444 .422 .401 .027
6-7 wk
ADG, ^  46.9 60.2 57.4 46.7 49.3 50.6 1.2
ADFI, g 149.4 166.3 163.0 131.1 153.7 155.3 10.9
Gain:feedb,c______________314________363________346________ 305________321________ 326_______ .007
'Data are means of two replicates of five broilers each; avg. initial wt. =  79 g.
*Sex effect, P <  .05, 
cCr linear effect, P < .04. 
dCr quadratic effect, P <  .06.
'Sex x  Or linear effect, P < .05. 
fSex x  Cr quadratic effect, P <  .06.
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containing 1,600 ppb Cr; however, large intestine weight was greatest in females fed 
400 ppb Cr (Sex x  Cr quadratic effect, P <  .01).
Dietary Cr supplementation decreased leg meat as a percentage of BW in birds 
fed 400 ppb Cr but increased leg meat as a percentage of BW in birds fed 1,600 ppb 
Cr (Cr quadratic effect, P < .10; Table 6.8). Abdominal fat pad weight as a 
percentage of BW was decreased more in females fed 1,600 ppb Cr than males fed 
1,600 ppb Cr (Sex X Cr linear effect, P < .09). Neither sex nor dietary Cr 
supplementation affected (P >  .10) breast or thigh meat as a percentage of BW.
During the fed state, males had higher plasma NEFA levels than females (Sex 
effect, P <  .08, Table 6.9). However, during the fasted state, females had higher 
plasma NEFA levels than males (Sex effect, P <  .03). Plasma cholesterol was 
increased by Cr supplementation during the fed (Cr linear effect, P <  .07) and 
fasted (Cr quadratic effect, P <  .02) states. During the fasted state, plasma 
cholesterol was higher in males than in females (Sex effect, P <  .08). Plasma 
insulin, in the fasted condition, was higher in females than in males (Sex effect,
P <  .03). Plasma insulin, in the fasted state, was increased by Cr supplementation 
(Cr quadratic, P <  .02). In the fed state, plasma insulin concentration was not 
affected (P >  .10) by treatment. Plasma glucose and glucagon concentrations were 
not affected (P >  .10) by treatment in either die fed or fasted state.
Carcass moisture, in males, decreased as dietary Cr level increased; however, 
in females, carcass moisture increased as dietary Cr level increased (Sex x  Cr linear






0 400 1,600 0 400 1,600
Organ weight, % BW
Liver 2.82 2.46 2.41 2.11 2.37 2.55 .11
Heart .50 .51 .52 .53 .55 .55 .02
Proveotriculusf .27 .25 .30 .27 .29 .29 .01
Ventriculusb 1.21 1.07 1.22 1.30 1.38 1.35 .06
Pancreas .16 .18 .19 .20 .20 .17 .01
Spleen .19 .17 .14 .15 .15 .22 .02
Small intestine 1.86 1.88 1.98 2.03 2.05 1.85 .05
Large intestine' .47 .51 .61 .49 .57 .49 .01
Tissue weight, % BW
Breast meat 11.94 12.07 12.36 12.82 11.70 13.49 .57
Leg meaf 2.92 2.82 3.36 3.00 2.74 2.93 .10
Thigh meat 3.73 3.75 3.84 3.57 3.34 3.91 .14
Abdominal fat pad4 1.49 1.65 1.19 1.82 1.79 1.25 .15
'Data are means of two replicates of five broilers each; avg. initial wt. =  79 g. 
bSex effect, P <  .07.
'Cr quadratic effect. P < .10. 
dSex x  Cr linear effect, P <  .09.
'Sex x  Cr quadratic effect, P <  .01. 
fSex x  Cr quadratic effect, P <  .05.
Table 6.9. Effect of dietary chromium on plasma metabolites and hormones of 5 to 54-day-old broilers (Exp. 3)*
 Male Female
Dietary Cr. Mg/kg Pooled
Item 0 400 1,600 0 400 1,600 SEM
Fed
Cholesterol, mmol/Ld 3.0 3.2 3.0 3.0 2.9 3.0 .1
NEFA, mEq/L* .33 .33 .32 .32 .29 .28 .02
Glucose, mmol/L 12.6 12.0 12.5 12.0 11.4 11.8 .5
Insulin, ng/mL .72 .98 .92 .98 1.36 1.13 .19
Glucagon, pg/mL 225.6 220.8 229.7 485.9 145.8 358.8 118.3
Fasted
Cholesterol, mmol/Lc,c 3.2 3.4 3.6 3.4 3.2 3.1 .1
NEFA, mEq/Lb .49 .50 .51 -55 .59 .58 .03
Glucose, mmol/L 10.6 10.8 10.8 10.9 10.5 10.8 .3
Insulin, ng/mL**-* .15 .24 .36 .44 .34 .34 .04
Glucagon. pg/mL 664.6 836.6 861.6 1162.2 1095.4 714.0 232.2
“Data are means of two replicates of five broilers each. 
bSex effect, P <  .03.
*Sex effect, P <  .08 
dCr linear effect, P <  .07.
'Cr quadratic effect. P < .02.
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effect, P <  .04) (Table 6.10). In males, carcass fat percentage increased as dietary 
Cr level increased; however, in females, carcass fat percentage decreased as dietary 
Cr level increased (Sex x  Cr linear effect, P <  .04). Carcass ash and CP, as a 
percentage of DM, were not affected (P >  .10) by treatment.
Gut moisture was higher in males than in females (Sex effect, P <  .06) but 
was not affected (P >  .10) by dietary Cr supplementation. Gut fat percentage in 
males was the highest when fed 400 ppb Cr; however, in females, dietary Cr 
decreased Gut fat percentage (Sex x  Cr quadratic effect, P <  .03). Gut ash as a 
percentage of DM was decreased as dietary Cr level increased (Cr linear effect,
P <  .01). Gut CP as a percentage of DM was not affected (P >  .10) by treatment.
White meat moisture was higher in males than in females (Sex effect,
P <  .06). White meat moisture, in males, decreased when fed 400 ppb Cr; 
however, in females, white meat moisture increased when fed 400 ppb Cr (Sex x  
Cr quadratic effect, P <  .03). White meat fat and CP were not affected (P >  .10) 
by treatment. White meat ash percentage was higher in females than in males (Sex 
effect, P <  .06).
Dark meat moisture and CP were higher in females than in males (Sex effect,
P <  .06). Dark meat CP as a percentage of DM was higher in females than in 
males (Sex effect, P <  .06). Dark meat fat and ash percentage were not affected 
(P > .  10) by treatment.
I
Male Female
*™̂ "“ — ^ — — — m h — « » »  _ _ m ^ _
Dietary Cr. ^g/kg Pooled
Item 0 400 1,600 0 400 1,600 SET
Carcass
Moisture, %c 62.2 61.2 61.6 59.3 60.1 62.8 .6
Fat, %e 15.2 17.4 16.7 18.5 18.3 14.5 .7
CP, % DM 50.1 47.1 51.8 46.4 45.2 48.8 2.1
Ash, % DM 8.8 8.4 8.5 7.8 7.9 8.6 .3
Gut
Moisture, %h 70.6 68.6 70.6 65.5 67.0 66.8 .8
Fat, %bAf 8.3 10.7 8.3 12.5 9.6 9.4 .7
CP, %DM 61.7 56.4 59.2 51.5 58.1 57.0 3.7
Ash, % DM0 5.5 4.1 5.2 4.7 5.3 4.2 .2
White meat
Moisture, %kAf 71.8 71.5 71.8 68.8 70.4 70.4 .3
Fat, % .3 .6 .4 .6 .3 .8 .4
CP, % DM 87.5 87.7 83.5 90.6 92.0 92.3 4.3




Moisture, %b-eAe’f 71.7 75.7 79.7
Fat, % 5.8 5.6 5.8
CP, %DM* 63.8 66.1 67.2
Ash, % DM 3.8 3.5 3.8
*Data are means of two replicates of three broilers each. 
bSex effect, P <  .06. 
eCr linear effect, P <  .01. 
dCr quadratic effect, P <  .06.
°Sex x  Cr linear effect, P <  .04. 
fSex x  Cr quadratic effect, P <  .03.
73.7 77.7 81.7 .5
5.4 6.8 6.5 .8
73.0 69.7 72.7 2.6




Supplemental dietary Cr did not affect (P >  .10) growth performance (Table 
6.11). Dietary Cr also did not affect (P >  .10) glucose clearance during IVGTT or 
IVICT or insulin clearance during IVGTT. The concentrations of glucose and 
insulin across time for the IVGTT are shown in Figures 6.1 and 6.2, respectively. 
The plot of glucose concentrations during IVICT is shown in Figure 6.3. Plasma 
glucose was not different (P >  .10) between dietary treatments during the LSMM. 
However, plasma glucagon was lower (P <  .04) in broilers fed CrPic during the 
LSMM. The concentrations of glucose and glucagon during LSMM are shown in 
Figures 6.4 and 6.5, respectively.
Discussion
Supplemental dietary Cr affected ADG, ADFI, and gain:feed ratio 
inconsistently in broilers in this investigation. Steele and Rosebrough (1979) 
reported increased growth rate and feed efficiency of turkey poults fed diets 
supplemented with 20 ppm Cr as Cr+J. Steele and Rosebrough (1981) also reported 
increased growth rate, as well as increased lipogenesis, of poults fed 20 ppm Cr. 
However, the increase in lipogenesis did not increase liver lipid content.
Rosebrough and Steele (1981) reported that 20 ppm dietary Cr as CrCl3 increased in 
vitro incorporation of 14C-glucose into glycogen. Thus, apparently CrCl3 also is an 
active source of Cr in poultry, as opposed to data from the pig (Page et al., 1990).
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Table 6.11. Effect of dietary chromium on growth performance, and glucose and insulin 
clearance in broilers (Exp. 4)
Dietary Cr. ue/ke. Pooled
Item_____________________________ 0  200_____ SD
Growth Performance
ADG, g 50.6 46.7 4.5
A D FI.g 135.1 134.0 6.2
Gain: feed .374 .348 .023
Intravenous Glucose Tolerance Test 
Glucose, 15 to 45 min 
Clearance, %/min 2.59 (6) 2.22 (7) .37
Half-life, min 27.2(6) 32.2(7) 5.0
Insulin, 15 to 30 min 
Clearance, %/min 10.92 (4) 8.43 (5) 2.96
Half-life, min 6.96(4) 9.37(5) 4.05
Intravenous Insulin Challenge Test.
Glucose, 0 to 60 min 
Clearance, %/min 1.50(5) 1.32(6) .16
Half-life, min 47.0(5) 53.4(6) 5.6
*Growth performance data are from four replicates of five birds each (28 to 58 d of age; 
avg. initial wt. =  976 g). Clearance rate and half-life data are from 11 wk old broilers; 
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Figure 6.1. Effect of dietary chromium on glucose clearance in broilers during an 
intravenous glucose tolerance test. Broilers were fed a com-soybean meal diet 
without (O) or with (□) 200 n g Cr as chromium tripicolinate (CrPic)/kg diet. For 
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Figure 6.2. Effect of dietary chromium on insulin clearance in broilers during an 
intravenous glucose tolerance test. Broilers were fed a com-soybean meal diet 
without (O) or with (□) 200 Mg Cr as chromium tripicolinate (CrPic)/kg diet. For 
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Figure 6.3. Effect of dietary chromium on glucose clearance in broilers during an 
intravenous insulin challenge test. Broilers were fed a corn-soybean meal diet 
without (O) or with (□) 200 f*g Cr as chromium tripicolinate (CrPic)/kg diet. For 
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Figure 6.4. Effect of dietary chromium on plasma glucose concentrations in broilers 
during an intravenous least-sampling minimum model (LSMM) glucose tolerance 
test. Broilers were fed a com-soybean meal diet without (O) or with (□) 200 t+g Cr 
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Figure 6.5. Effect of dietary chromium on plasma glucagon concentrations in 
broilers during an intravenous least-sampling minimum model (LSMM) glucose 
tolerance test. Broilers were fed a com-soybean meal diet without (O) or with (□) 
200 Mg Cr as chromium tripicolinate (CrPic)/kg diet.
Page et al. (1993a) reported increased, decreased, and no change in ADG of 
pigs fed CrPic. Other investigators have reported inconsistent (yet primarily a lack 
of) effects of dietary Cr on growth performance of pigs (Boleman et al., 1995; Page 
et al., 1993a,b; Renteria and Cuaron, 1993), lambs (Gentry et al., 1995; Kitchalong 
et al., 1995), calves (Bunting et al,, 1994) and steers (Claeys et al., 1994). 
However, it may be inappropriate to compare the results of other investigators with 
our data because of the dramatic differences in length of treatment, physiological 
and chronological age of the animals, as well as species differences. These same 
factors may partially explain why we were not able to detect an increase in N 
balance, in Exp. 1, as reported by Britton et al (1968) in lambs. Kitchalong et al. 
(1993) also reported no effect of CrPic on N balance of lambs.
Supplemental dietary Cr did not affect the percentage of CP, moisture, or 
ether extract in breast and leg muscle samples in Exp. 1. This lack of effect on meat 
characteristics is in agreement with other data from pigs (Page et al., 1992b). 
However, Data from Exp. 2 and 3 indicate that Cr is affecting the composition of 
body components. The increased weight of tire ventriculus, a highly muscular 
organ, follows the increased muscling reported by other investigators in pigs 
(Boleman et al., 1995; Lindemann et al., 1995; Mooney and Cromwell, 1995; Page 
et al., 1993). Furthermore, in Exp. 3, dietary Cr supplementation increased CP in 
the carcass. Recall that the carcass did not contain the breast meat or the right leg 
and thigh meal. This suggests that dietary Cr may have subtle effects on multiple
carcass components or that Cr is affecting some individual carcass component that 
was not measured. In contrast to Exp. 1, in Exp. 3 the percentage of moisture in 
the dark meat was increased by dietary Cr supplementation. The positive association 
of moisture content with protein content and negative association of moisture content 
with fat content suggest that Cr may be increasing total carcass protein. In addition, 
Cr supplementation in Exp. 3 resulted in a reduction in abdominal fat pad weight, 
which is correlated with total carcass fat content. Thus, Cr may be affecting fat 
deposition and(or) protein deposition. The data of Mooney and Cromwell (1995) 
suggests that both protein and fat deposition arc affected simultaneously. Similarly, 
the increased carcass ash (Exp. 2) is in agreement with data from pigs (Boleman et 
al., 1995; Mooney and Cromwell, 1995). Thus, it appears that CrPic may be 
influencing the total amounts of body fat (less) and body CP (more) in broilers. The 
current data suggest that long-term feeding is more beneficial than short-term 
feeding. This is the opposite response that has been reported for one study with pigs 
(Boleman et al., 1995). However, it is wise to use caution when comparing these 
results. To more accurately describe the response to length of feeding Cr, broilers 
should be fed Cr different lengths of time, but all birds should be fed to a 
conventional finished broiler end point.
The influence of Cr on insulin function and glucose status of mammals is well 
documented; however, the importance of insulin in the metabolism of the chicken is 
not well established. The effects of Cr on the body composition of broiler chicks
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may implicate the importance of insulin in avian metabolism or it is possible that Cr 
is mediating its effects via other and/or additional mechanisms from insulin. 
Touchbum et al. (1981) reported a relationship between plasma glucose and insulin 
and body fat content of broilers. That is, broilers that have been selected for 
increased body fat content have lower fasting glucose and higher fasting insulin 
concentrations (Touchbum et al., 1981). However, in commercial broilers, such as 
those we used, that historically have been selected for increased rate of BW gain 
(and incidentally increased fat), it is not clear if the relationship between insulin and 
glucose and body tat remains. In Exp. 3, in the fasted condition, broilers had 
increased plasma insulin due to Cr supplementation, but no change was seen in 
glucose concentration. If the relationship as described by Touchbum et al. (1981) is 
true then it would follow that the broilers given supplemental Cr would contain more 
fat. However, the data do not support this conclusion. Due to the lack of effect of 
dietary Cr on glucose and insulin clearance in this investigation, it is not possible to 
draw unequivocal conclusions regarding the relationship between dietary Cr 
supplementation and plasma glucose and plasma insulin and body composition.
It is not possible to draw many conclusions from the LSMM data. However, 
it is interesting that the dramatic rise in glucagon that occurred in both treatment 
groups following the insulin infusion was not capable of inducing a concomitant 
increase in blood glucose. In addition, the overall lower level of plasma glucagon 
observed in the broilers fed Cr is perplexing. Glucagon is highly lipolytic in the
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avian species. Lower plasma glucagon would imply that the birds fed Cr may 
deposit more fat; however, the carcass composition data do not support this.
The trend toward increased protein and decreased fat in the carcass of broilers 
indicates that Cr as CrPic may be of economic importance in the poultry industry. 
Providing the human population a healthier (less fat) product is a desirable goal from 
both a human and animal nutritionist viewpoint
Implications
Dietary chromium may affect metabolism of broilers and thereby also affect 
body composition. Increased protein and decreased fat content of chicken meat 
would be of considerable benefit to the world human population that consumes the 
meat. However, conduction o f conventional floor pen studies and industry carcass 
measurements would better quantify the effect of dietary chromium on the body 
composition of chickens. Dietary chromium supplementation may be a means of 
decreasing fat content and increasing protein content of broilers.
CHAPTER VII 
OVERALL SUMMARY AND CONCLUSIONS
The results of the first experiment indicate that the puiported effects of dietary 
Cr supplementation on body composition are not always evident. Dietary Cr, in 
both inorganic and organic forms, did not decrease tenth rib fat thickness nor 
increase longissimus muscle area, as has been reported by other investigators. 
However, other researchers have reported increased carcass protein and decreased 
carcass fat in pigs fed supplemental Cr when linear carcass measurements (i.e., tenth 
rib fat thickness and longissimus muscle area) were not affected. Only linear 
carcass measurements were taken in experiment one; therefore, subtle changes in 
carcass composition may have occurred. The reasons for a less dramatic effect, 
perhaps, on carcass composition are not known. Some investigators have 
hypothesized that the level of stress, genotype differences, or Cr status may be 
responsible for the different results obtained from dietary Cr supplementation. The 
second experiment suggested that dietary Cr supplementation as Cr chloride 
hexahydrate, Cr nicotinate, or Cr tripicolinate did not affect glucose and insulin 
clearance in pigs given intravenous glucose tolerance tests or intravenous insulin 
challenge tests. Thus, again the reason for the discrepant results between 
experiment two and other experiments with Cr tripicolinate from the same 
laboratory are not known. In experiment three, decreased pen size and decreased 
dietary crude protein concentration were not effective in inducing a Cr effect on
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linear carcass traits of growing-finishing pigs. The following are possible reasons:
1) the chronic effect of decreased pen size and decreased dietary crude protein were 
not effective as stressors, 2) the pigs were able to adapt to the stress, or 3) the 
effects of dietary Cr are not mediated through stress-related mechanisms. In 
experiment four, body composition of broiler chickens was affected by dietary Cr 
supplementation. Although the data are inconclusive, they suggest that dietary Cr 
supplementation as Cr tripicolinate is effective in increasing carcass crude protein 
and decreasing carcass fat content. It is not clear if the effects on body composition 
were mediated through glucose or insulin utilization. Data collected under practical 
growing conditions with industry carcass measurements would be of great benefit in 
clarifying the effectiveness of dietary Cr in modulating carcass composition of 
broilers. The conditions under which dietary Cr supplementation is beneficial to 
livestock species and thus the livestock industry need to be better characterized in 
order to provide firmer recommendations on the use of dietary Cr.
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